cephem - Ontology Report - Rat Genome Database

Submit Data | Help | Video Tutorials | News | Publications | Download | REST API | Citing RGD | Contact

Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

{{ watchLinkText }}

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:	cephem	go back to main search page
Accession:	CHEBI:38311	browse the term
Synonyms:	related_synonym:	cephems

show annotations for term's descendants Sort by:
Rat (549) Mouse (535) Human (539) Chinchilla (0) Bonobo (0) Dog (0) Squirrel (0) Pig (1) Green Monkey (0) Naked Mole-rat (0) All
Genes (549)

7beta-aminocephalosporanic acid

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

adenosine monophosphate deaminase 3

increases expression

7-aminocephalosporanic acid results in increased expression of AMPD3 mRNA

NCBI chr 1:164,884,823...164,929,899
Ensembl chr 1:164,885,320...164,929,887

G

ferritin heavy chain 1

increases expression

7-aminocephalosporanic acid results in increased expression of FTH1 mRNA

NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424

G

ferritin light chain 1

increases expression

7-aminocephalosporanic acid results in increased expression of FTL mRNA

NCBI chr 1:95,936,387...95,938,234
Ensembl chr 1:95,936,387...95,939,725
Ensembl chr10:95,936,387...95,939,725
Ensembl chr 2:95,936,387...95,939,725

G

glutamate cysteine ligase, modifier subunit

increases expression

7-aminocephalosporanic acid results in increased expression of GCLM mRNA

NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535

G

heme oxygenase 1

increases expression

7-aminocephalosporanic acid results in increased expression of HMOX1 mRNA

NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079

G

MYC proto-oncogene, bHLH transcription factor

increases expression

7-aminocephalosporanic acid results in increased expression of MYC mRNA

NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630

G

NAD(P)H quinone dehydrogenase 1

increases expression

7-aminocephalosporanic acid results in increased expression of NQO1 mRNA

NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557

G

SEL1L family member 3

increases expression

7-aminocephalosporanic acid results in increased expression of SEL1L3 mRNA

NCBI chr14:57,775,515...57,882,076
Ensembl chr14:57,775,501...57,882,644

G

solute carrier family 7 member 11

increases expression

7-aminocephalosporanic acid results in increased expression of SLC7A11 mRNA

NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536

G

sequestosome 1

increases expression

7-aminocephalosporanic acid results in increased expression of SQSTM1 mRNA

NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673

G

spectrin repeat containing nuclear envelope protein 2

decreases expression

7-aminocephalosporanic acid results in decreased expression of SYNE2 mRNA

NCBI chr 6:94,537,088...94,848,085
Ensembl chr 6:94,537,088...94,848,064

G

troponin T2, cardiac type

decreases expression

7-aminocephalosporanic acid results in decreased expression of TNNT2 mRNA

NCBI chr13:47,267,325...47,285,390
Ensembl chr13:47,267,204...47,285,388

G

thioredoxin reductase 1

increases expression

7-aminocephalosporanic acid results in increased expression of TXNRD1 mRNA

NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863

cefaclor

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

ATP binding cassette subfamily B member 11

multiple interactions
decreases activity

Cefaclor inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid]
Cefaclor results in decreased activity of ABCB11 protein

NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730

G

cytochrome P450, family 3, subfamily a, polypeptide 2

increases expression

Cefaclor results in increased expression of CYP3A4 mRNA; Cefaclor results in increased expression of CYP3A4 protein

NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008

G

solute carrier family 22 member 6

multiple interactions

Cefaclor inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid]

NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173

G

solute carrier family 22 member 8

increases uptake
multiple interactions

SLC22A8 protein results in increased uptake of Cefaclor
Cefaclor inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]

NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450

cefadroxil

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

cytochrome P450, family 3, subfamily a, polypeptide 2

increases expression

Cefadroxil results in increased expression of CYP3A4 mRNA; Cefadroxil results in increased expression of CYP3A4 protein

NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008

G

RT1 class Ib, locus M3, gene 1

affects expression

Cefadroxil affects the expression of HLA-G mRNA

NCBI chr20:1,323,976...1,328,126
Ensembl chr20:1,287,521...1,328,117

cefaloridine

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

arylacetamide deacetylase

increases expression

Cephaloridine results in increased expression of AADAC mRNA

NCBI chr 2:144,163,436...144,186,086
Ensembl chr 2:144,135,319...144,174,734

G

aminoadipate-semialdehyde synthase

decreases expression

Cephaloridine results in decreased expression of AASS mRNA

NCBI chr 4:51,606,461...51,663,136
Ensembl chr 4:51,606,462...51,663,136

G

ATP-binding cassette, sub-family B member 1B

increases expression

Cephaloridine results in increased expression of ABCB1B mRNA

NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199

G

ATP binding cassette subfamily C member 2

increases expression

Cephaloridine results in increased expression of ABCC2 mRNA

NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238

G

aminocarboxymuconate semialdehyde decarboxylase

decreases expression

Cephaloridine results in decreased expression of ACMSD mRNA

NCBI chr13:39,200,412...39,245,954
Ensembl chr13:39,200,314...39,245,209

G

acyl-CoA thioesterase 9

increases expression

Cephaloridine results in increased expression of ACOT9 mRNA

NCBI chr X:40,073,197...40,123,573
Ensembl chr X:40,064,810...40,123,559

G

acyl-CoA synthetase medium-chain family member 5

decreases expression

Cephaloridine results in decreased expression of ACSM5 mRNA

NCBI chr 1:173,870,873...173,896,838
Ensembl chr 1:173,863,041...173,898,588

G

ADAM metallopeptidase domain 8

decreases expression

Cephaloridine results in decreased expression of ADAM8 mRNA

NCBI chr 1:194,776,559...194,789,330
Ensembl chr 1:194,770,060...194,788,801

G

adhesion G protein-coupled receptor E1

increases expression

Cephaloridine results in increased expression of ADGRE1 mRNA

NCBI chr 9:2,242,476...2,398,000
Ensembl chr 9:2,242,474...2,398,000

G

adenosine A2a receptor

increases expression

Cephaloridine results in increased expression of ADORA2A mRNA

NCBI chr20:13,315,848...13,333,386
Ensembl chr20:13,315,853...13,333,386

G

adrenoceptor alpha 1D

increases expression

Cephaloridine results in increased expression of ADRA1D mRNA

NCBI chr 3:118,793,356...118,809,354
Ensembl chr 3:118,793,346...118,809,354

G

aftiphilin

decreases expression

Cephaloridine results in decreased expression of AFTPH mRNA

NCBI chr14:94,871,429...94,925,625
Ensembl chr14:94,871,429...94,925,376

G

aldo-keto reductase family 1 member B1

increases expression

Cephaloridine results in increased expression of AKR1B1 mRNA

NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157

G

aldo-keto reductase family 1, member D1

increases expression

Cephaloridine results in increased expression of AKR1D1 mRNA

NCBI chr 4:66,154,246...66,187,505
Ensembl chr 4:66,154,248...66,186,372

G

5'-aminolevulinate synthase 1

increases expression

Cephaloridine results in increased expression of ALAS1 mRNA

NCBI chr 8:106,876,514...106,889,917
Ensembl chr 8:106,876,514...106,889,917

G

aldehyde dehydrogenase 3 family, member A1

increases expression

Cephaloridine results in increased expression of ALDH3A1 mRNA

NCBI chr10:45,892,993...45,902,680
Ensembl chr10:45,892,924...45,902,681

G

aldehyde dehydrogenase 3 family, member B1

increases expression

Cephaloridine results in increased expression of ALDH3B1 mRNA

NCBI chr 1:201,145,309...201,162,675
Ensembl chr 1:201,145,309...201,163,921

G

aldolase, fructose-bisphosphate A

affects expression

Cephaloridine affects the expression of ALDOA mRNA

NCBI chr 1:181,402,275...181,407,476
Ensembl chr 1:181,402,275...181,406,182

G

APC membrane recruitment protein 2

decreases expression

Cephaloridine results in decreased expression of AMER2 mRNA

NCBI chr15:34,525,352...34,535,660
Ensembl chr15:34,524,542...34,528,455

G

adhesion molecule with Ig like domain 2

increases expression

Cephaloridine results in increased expression of AMIGO2 mRNA

NCBI chr 7:128,391,493...128,394,589
Ensembl chr 7:128,390,412...128,394,695

G

adenosine monophosphate deaminase 1

increases expression

Cephaloridine results in increased expression of AMPD1 mRNA

NCBI chr 2:190,598,707...190,619,938
Ensembl chr 2:190,598,700...190,619,938

G

adenosine monophosphate deaminase 3

increases expression

Cephaloridine results in increased expression of AMPD3 mRNA

NCBI chr 1:164,884,823...164,929,899
Ensembl chr 1:164,885,320...164,929,887

G

angiopoietin-like 4

increases expression

Cephaloridine results in increased expression of ANGPTL4 mRNA

NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519

G

anillin, actin binding protein

decreases expression

Cephaloridine results in decreased expression of ANLN mRNA

NCBI chr 8:20,858,227...20,921,602
Ensembl chr 8:20,858,228...20,921,538

G

annexin A13

decreases expression

Cephaloridine results in decreased expression of ANXA13 mRNA

NCBI chr 7:89,884,356...89,936,907
Ensembl chr 7:89,884,356...89,936,907

G

annexin A7

increases expression

Cephaloridine results in increased expression of ANXA7 mRNA

NCBI chr15:3,821,798...3,849,659
Ensembl chr15:3,821,845...3,849,385

G

amyloid P component, serum

decreases expression

Cephaloridine results in decreased expression of APCS mRNA

NCBI chr13:85,373,219...85,374,195
Ensembl chr13:85,373,220...85,374,298

G

apolipoprotein A4

increases expression

Cephaloridine results in increased expression of APOA4 mRNA

NCBI chr 8:46,539,083...46,541,464
Ensembl chr 8:46,539,082...46,541,469

G

apolipoprotein B

increases expression

Cephaloridine results in increased expression of APOB mRNA

NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497

G

apolipoprotein C2

increases expression

Cephaloridine results in increased expression of APOC2 mRNA

NCBI chr 1:79,329,429...79,334,397
Ensembl chr 1:79,329,428...79,334,476

G

apolipoprotein L domain containing 1

decreases expression

Cephaloridine results in decreased expression of APOLD1 mRNA

NCBI chr 4:167,768,437...167,825,706
Ensembl chr 4:167,818,271...167,825,706

G

ARFGEF family member 3

decreases expression

Cephaloridine results in decreased expression of ARFGEF3 mRNA

NCBI chr 1:13,245,578...13,404,319
Ensembl chr 1:13,244,830...13,404,084

G

Rho GTPase activating protein 35

decreases expression

Cephaloridine results in decreased expression of ARHGAP35 mRNA

NCBI chr 1:77,202,436...77,319,298
Ensembl chr 1:77,202,436...77,319,298

G

AT-rich interaction domain 5A

increases expression

Cephaloridine results in increased expression of ARID5A mRNA

NCBI chr 9:38,534,612...38,549,467
Ensembl chr 9:38,534,590...38,547,597

G

anti-silencing function 1B histone chaperone

increases expression

Cephaloridine results in increased expression of ASF1B mRNA

NCBI chr19:24,181,024...24,195,604
Ensembl chr19:24,181,028...24,195,549

G

ASH1 like histone lysine methyltransferase

decreases expression

Cephaloridine results in decreased expression of ASH1L mRNA

NCBI chr 2:174,346,267...174,483,057
Ensembl chr 2:174,346,150...174,483,055

G

asparagine synthetase (glutamine-hydrolyzing)

increases expression

Cephaloridine results in increased expression of ASNS mRNA

NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423

G

ATPase family, AAA domain containing 1

increases expression

Cephaloridine results in increased expression of ATAD1 mRNA

NCBI chr 1:230,544,227...230,610,524
Ensembl chr 1:230,544,047...230,596,548

G

ATPase family, AAA domain containing 2

increases expression

Cephaloridine results in increased expression of ATAD2 mRNA

NCBI chr 7:89,634,123...89,676,738
Ensembl chr 7:89,634,123...89,676,738

G

activating transcription factor 3

decreases expression

Cephaloridine results in decreased expression of ATF3 mRNA

NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631

G

atlastin GTPase 1

increases expression

Cephaloridine results in increased expression of ATL1 mRNA

NCBI chr 6:88,377,168...88,475,242
Ensembl chr 6:88,377,239...88,475,204

G

ATPase phospholipid transporting 11C

decreases expression

Cephaloridine results in decreased expression of ATP11C mRNA

NCBI chr X:138,564,459...138,752,116
Ensembl chr X:138,565,836...138,751,204

G

ATPase H+/K+ transporting non-gastric alpha2 subunit

increases expression

Cephaloridine results in increased expression of ATP12A mRNA

NCBI chr15:30,443,571...30,468,229
Ensembl chr15:30,443,571...30,468,229

G

aurora kinase B

decreases expression

Cephaloridine results in decreased expression of AURKB mRNA

NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837

G

Beta-1,3-galactosyltransferase 2

decreases expression

Cephaloridine results in decreased expression of B3GALT2 mRNA

NCBI chr13:55,389,406...55,398,419
Ensembl chr13:55,389,406...55,398,419

G

UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7

decreases expression

Cephaloridine results in decreased expression of B3GNT7 mRNA

NCBI chr 9:86,956,220...86,960,171
Ensembl chr 9:86,956,220...86,960,170

G

BAG cochaperone 3

increases expression

Cephaloridine results in increased expression of BAG3 mRNA

NCBI chr 1:183,103,038...183,126,862
Ensembl chr 1:183,102,871...183,126,858

G

BCL2-antagonist/killer 1

increases expression

Cephaloridine results in increased expression of BAK1 mRNA

NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264

G

BRCA1 associated RING domain 1

increases expression

Cephaloridine results in increased expression of BARD1 mRNA

NCBI chr 9:72,616,070...72,694,553
Ensembl chr 9:72,623,155...72,694,265

G

basic leucine zipper ATF-like transcription factor

increases expression

Cephaloridine results in increased expression of BATF mRNA

NCBI chr 6:105,353,715...105,376,051
Ensembl chr 6:105,353,715...105,376,051

G

Bcl2-like 1

affects expression

Cephaloridine affects the expression of BCL2L1 mRNA

NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
Ensembl chr 1:141,253,523...141,303,479

G

brain expressed X-linked 2

increases expression

Cephaloridine results in increased expression of BEX1 mRNA

NCBI chr X:99,019,847...99,021,375
Ensembl chr X:99,019,000...99,021,503

G

brain expressed, X-linked 4

increases expression

Cephaloridine results in increased expression of BEX4 mRNA

NCBI chr X:99,131,985...99,133,417
Ensembl chr X:99,131,942...99,133,531

G

basic helix-loop-helix family, member e41

increases expression

Cephaloridine results in increased expression of BHLHE41 mRNA

NCBI chr 4:178,834,264...178,838,618
Ensembl chr 4:178,834,271...178,838,468

G

baculoviral IAP repeat-containing 3

increases expression

Cephaloridine results in increased expression of BIRC3 mRNA

NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802

G

biliverdin reductase B

increases expression

Cephaloridine results in increased expression of BLVRB mRNA

NCBI chr 1:82,738,646...82,756,312
Ensembl chr 1:82,738,695...82,770,375

G

bactericidal/permeability-increasing protein

increases expression

Cephaloridine results in increased expression of BPI mRNA

NCBI chr 3:146,909,626...146,936,487
Ensembl chr 3:146,909,629...146,936,221

G

BRCA1 interacting DNA helicase 1

increases expression

Cephaloridine results in increased expression of BRIP1 mRNA

NCBI chr10:70,907,266...71,031,502
Ensembl chr10:70,907,371...71,030,324

G

barttin CLCNK type accessory subunit beta

increases expression

Cephaloridine results in increased expression of BSND mRNA

NCBI chr 5:121,251,774...121,260,571
Ensembl chr 5:121,251,774...121,260,571

G

BTG anti-proliferation factor 2

decreases expression

Cephaloridine results in decreased expression of BTG2 mRNA

NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628

G

BUB1 mitotic checkpoint serine/threonine kinase B

decreases expression

Cephaloridine results in decreased expression of BUB1B mRNA

NCBI chr 3:105,563,089...105,615,547
Ensembl chr 3:105,563,138...105,615,547

G

similar to human chromosome 16 open reading frame 89

increases expression

Cephaloridine results in increased expression of C10H16ORF89 mRNA

NCBI chr10:10,361,909...10,371,046
Ensembl chr10:10,361,948...10,371,046

G

C1q and TNF related 1

increases expression

Cephaloridine results in increased expression of C1QTNF1 mRNA

NCBI chr10:103,660,319...103,681,662
Ensembl chr10:103,660,327...103,681,660

G

complement C5

decreases expression

Cephaloridine results in decreased expression of C5 mRNA

NCBI chr 3:18,270,696...18,361,994
Ensembl chr 3:18,270,696...18,361,994

G

complement C6

increases expression

Cephaloridine results in increased expression of C6 mRNA

NCBI chr 2:53,846,028...53,921,279
Ensembl chr 2:53,851,985...53,921,275

G

calcium voltage-gated channel subunit alpha1 H

increases expression

Cephaloridine results in increased expression of CACNA1H mRNA

NCBI chr10:14,390,104...14,448,204
Ensembl chr10:14,390,113...14,448,376

G

calcium voltage-gated channel auxiliary subunit gamma 3

increases expression

Cephaloridine results in increased expression of CACNG3 mRNA

NCBI chr 1:177,201,361...177,297,019
Ensembl chr 1:177,201,288...177,297,024

G

calbindin 1

increases expression

Cephaloridine results in increased expression of CALB1 mRNA

NCBI chr 5:29,375,624...29,402,532
Ensembl chr 5:29,375,642...29,402,431

G

calbindin 2

decreases expression

Cephaloridine results in decreased expression of CALB2 mRNA

NCBI chr19:38,114,435...38,141,438
Ensembl chr19:38,114,424...38,141,438

G

calreticulin

increases expression

Cephaloridine results in increased expression of CALR mRNA

NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414

G

CaM kinase-like vesicle-associated

increases expression

Cephaloridine results in increased expression of CAMKV mRNA

NCBI chr 8:108,626,821...108,641,169
Ensembl chr 8:108,626,821...108,641,169

G

calnexin

increases expression

Cephaloridine results in increased expression of CANX mRNA

NCBI chr10:34,623,865...34,656,866
Ensembl chr10:34,625,191...34,656,821

G

catalase

affects expression

Cephaloridine affects the expression of CAT protein

NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478

G

coiled-coil domain containing 113

increases expression

Cephaloridine results in increased expression of CCDC113 mRNA

NCBI chr19:9,497,000...9,516,917
Ensembl chr19:9,496,886...9,516,923

G

C-C motif chemokine ligand 17

increases expression

Cephaloridine results in increased expression of CCL17 mRNA

NCBI chr19:10,202,128...10,203,903
Ensembl chr19:10,202,128...10,203,819

G

C-C motif chemokine ligand 19

increases expression

Cephaloridine results in increased expression of CCL19 mRNA

NCBI chr 5:56,963,364...56,965,308
Ensembl chr 5:56,963,364...56,965,308

G

C-C motif chemokine ligand 20

increases expression

Cephaloridine results in increased expression of CCL20 mRNA

NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629

G

C-C motif chemokine ligand 28

increases expression

Cephaloridine results in increased expression of CCL28 mRNA

NCBI chr 2:51,601,354...51,625,999
Ensembl chr 2:51,601,331...51,625,997

G

C-C motif chemokine ligand 3

decreases expression

Cephaloridine results in decreased expression of CCL3 mRNA

NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938

G

C-C motif chemokine ligand 4

decreases expression

Cephaloridine results in decreased expression of CCL4 mRNA

NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231

G

cellular communication network factor 2

decreases expression

Cephaloridine results in decreased expression of CCN2 mRNA

NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734

G

cyclin A2

decreases expression

Cephaloridine results in decreased expression of CCNA2 mRNA

NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577

G

cyclin B1

decreases expression

Cephaloridine results in decreased expression of CCNB1 mRNA

NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172

G

cyclin B2

decreases expression

Cephaloridine results in decreased expression of CCNB2 mRNA

NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874

G

cyclin E1

increases expression

Cephaloridine results in increased expression of CCNE1 mRNA

NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101

G

cyclin E2

increases expression

Cephaloridine results in increased expression of CCNE2 mRNA

NCBI chr 5:24,285,078...24,298,258
Ensembl chr 5:24,284,922...24,297,632

G

CD52 molecule

decreases expression

Cephaloridine results in decreased expression of CD52 mRNA

NCBI chr 5:146,319,789...146,321,348
Ensembl chr 5:146,319,969...146,321,348

G

Cd72 molecule

increases expression

Cephaloridine results in increased expression of CD72 mRNA

NCBI chr 5:57,697,361...57,704,980
Ensembl chr 5:57,697,367...57,704,725

G

CD86 molecule

increases expression

Cephaloridine results in increased expression of CD86 mRNA

NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818

G

cell division cycle 42

decreases expression

Cephaloridine results in decreased expression of CDC42 mRNA

NCBI chr 5:149,555,069...149,593,239
Ensembl chr 5:149,553,724...149,593,111

G

cell division cycle 45

increases expression

Cephaloridine results in increased expression of CDC45 mRNA

NCBI chr11:82,185,427...82,210,630
Ensembl chr11:82,185,473...82,210,619

G

cell division cycle 6

increases expression

Cephaloridine results in increased expression of CDC6 mRNA

NCBI chr10:83,864,189...83,878,011
Ensembl chr10:83,864,638...83,878,011

G

cell division cycle associated 2

decreases expression

Cephaloridine results in decreased expression of CDCA2 mRNA

NCBI chr15:41,895,946...41,942,226
Ensembl chr15:41,895,901...41,941,611

G

cyclin-dependent kinase 1

decreases expression

Cephaloridine results in decreased expression of CDK1 mRNA

NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408

G

cyclin dependent kinase like 1

decreases expression

Cephaloridine results in decreased expression of CDKL1 mRNA

NCBI chr 6:88,224,154...88,273,434
Ensembl chr 6:88,224,143...88,270,276

G

cyclin-dependent kinase inhibitor 1A

decreases expression

Cephaloridine results in decreased expression of CDKN1A mRNA

NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585

G

cyclin-dependent kinase inhibitor 1B

decreases expression

Cephaloridine results in decreased expression of CDKN1B mRNA

NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982

G

chromatin licensing and DNA replication factor 1

increases expression

Cephaloridine results in increased expression of CDT1 mRNA

NCBI chr19:50,620,713...50,625,659
Ensembl chr19:50,620,713...50,625,659

G

CEA cell adhesion molecule 16, tectorial membrane component

increases expression

Cephaloridine results in increased expression of CEACAM16 mRNA

NCBI chr 1:79,514,975...79,524,871
Ensembl chr 1:79,514,975...79,524,871

G

centromere protein K

increases expression

Cephaloridine results in increased expression of CENPK mRNA

NCBI chr 2:35,360,390...35,421,372
Ensembl chr 2:35,360,132...35,385,706

G

centromere protein Q

increases expression

Cephaloridine results in increased expression of CENPQ mRNA

NCBI chr 9:19,957,122...19,972,807
Ensembl chr 9:19,957,048...19,972,789

G

carboxylesterase-like 1

decreases expression

Cephaloridine results in decreased expression of CESL1 mRNA

NCBI chr19:22,670,709...23,006,329
Ensembl chr19:22,670,712...22,712,608

G

chromatin assembly factor 1 subunit A

increases expression

Cephaloridine results in increased expression of CHAF1A mRNA

NCBI chr 9:873,953...900,701
Ensembl chr 9:874,051...900,654

G

chromatin assembly factor 1 subunit B

increases expression

Cephaloridine results in increased expression of CHAF1B mRNA

NCBI chr11:33,200,894...33,221,076
Ensembl chr11:33,200,981...33,221,070

G

chromodomain helicase DNA binding protein 4

decreases expression

Cephaloridine results in decreased expression of CHD4 mRNA

NCBI chr 4:157,898,503...157,931,632
Ensembl chr 4:157,899,391...157,931,541

G

chromodomain helicase DNA binding protein 6

decreases expression

Cephaloridine results in decreased expression of CHD6 mRNA

NCBI chr 3:149,596,509...149,757,765
Ensembl chr 3:149,596,509...149,757,755

G

checkpoint kinase 1

increases expression

Cephaloridine results in increased expression of CHEK1 mRNA

NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009

G

carbohydrate sulfotransferase 7

decreases expression

Cephaloridine results in decreased expression of CHST7 mRNA

NCBI chr X:2,396,260...2,432,828
Ensembl chr X:2,393,874...2,432,840

G

chromosome transmission fidelity factor 18

increases expression

Cephaloridine results in increased expression of CHTF18 mRNA

NCBI chr10:14,743,006...14,751,044
Ensembl chr10:14,742,621...14,751,050

G

cartilage intermediate layer protein

decreases expression

Cephaloridine results in decreased expression of CILP mRNA

NCBI chr 8:65,777,281...65,792,251
Ensembl chr 8:65,777,281...65,792,251

G

Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2

increases expression

Cephaloridine results in increased expression of CITED2 mRNA

NCBI chr 1:12,312,426...12,314,869
Ensembl chr 1:12,312,160...12,314,897

G

cytoskeleton associated protein 2

decreases expression

Cephaloridine results in decreased expression of CKAP2 mRNA

NCBI chr16:69,839,668...69,864,852
Ensembl chr16:69,839,630...69,864,913

G

claudin 14

increases expression

Cephaloridine results in increased expression of CLDN14 mRNA

NCBI chr11:33,232,281...33,329,440
Ensembl chr11:33,232,220...33,329,171

G

calsyntenin 2

decreases expression

Cephaloridine results in decreased expression of CLSTN2 mRNA

NCBI chr 8:98,020,406...98,637,232
Ensembl chr 8:98,021,666...98,637,731

G

c-Maf-inducing protein

decreases expression

Cephaloridine results in decreased expression of CMIP mRNA

NCBI chr19:45,304,597...45,510,653
Ensembl chr19:45,304,031...45,508,709

G

carnosine dipeptidase 1

decreases expression

Cephaloridine results in decreased expression of CNDP1 mRNA

NCBI chr18:77,984,886...78,030,837
Ensembl chr18:77,984,907...78,007,765

G

collagen type IV alpha 4 chain

decreases expression

Cephaloridine results in decreased expression of COL4A4 mRNA

NCBI chr 9:83,833,173...83,875,436
Ensembl chr 9:83,755,515...83,875,876

G

collagen type VII alpha 1 chain

increases expression

Cephaloridine results in increased expression of COL7A1 mRNA

NCBI chr 8:109,604,877...109,637,249
Ensembl chr 8:109,604,861...109,637,252

G

carnitine palmitoyltransferase 1B

increases expression

Cephaloridine results in increased expression of CPT1B mRNA

NCBI chr 7:120,491,354...120,500,833
Ensembl chr 7:120,491,354...120,500,404

G

cellular retinoic acid binding protein 1

increases expression

Cephaloridine results in increased expression of CRABP1 mRNA

NCBI chr 8:55,138,363...55,159,360
Ensembl chr 8:55,151,285...55,159,360

G

CREB binding protein

decreases expression

Cephaloridine results in decreased expression of CREBBP mRNA

NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888

G

cryptochrome circadian regulator 1

increases expression

Cephaloridine results in increased expression of CRY1 mRNA

NCBI chr 7:18,529,823...18,594,092
Ensembl chr 7:18,529,823...18,594,091

G

C-X-C motif chemokine ligand 1

decreases expression

Cephaloridine results in decreased expression of CXCL1 mRNA

NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215

G

C-X-C motif chemokine ligand 10

increases expression

Cephaloridine results in increased expression of CXCL10 mRNA

NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975

G

C-X-C motif chemokine ligand 13

increases expression

Cephaloridine results in increased expression of CXCL13 mRNA

NCBI chr14:13,608,894...13,613,965
Ensembl chr14:13,608,902...13,613,933

G

C-X-C motif chemokine ligand 14

increases expression

Cephaloridine results in increased expression of CXCL14 mRNA

NCBI chr17:8,317,930...8,325,956
Ensembl chr17:8,317,933...8,324,839

G

CXXC finger protein 4

decreases expression

Cephaloridine results in decreased expression of CXXC4 mRNA

NCBI chr 2:222,664,148...222,689,365
Ensembl chr 2:222,664,771...222,689,365

G

cytochrome b5 type A

increases expression

Cephaloridine results in increased expression of CYB5A mRNA

NCBI chr18:78,213,067...78,245,677
Ensembl chr18:78,202,342...78,258,535
Ensembl chr18:78,202,342...78,258,535

G

cytochrome P450, family 1, subfamily b, polypeptide 1

increases expression

Cephaloridine results in increased expression of CYP1B1 mRNA

NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917

G

cytochrome P450, family 24, subfamily a, polypeptide 1

decreases expression

Cephaloridine results in decreased expression of CYP24A1 mRNA

NCBI chr 3:159,275,947...159,290,383
Ensembl chr 3:159,275,947...159,290,383

G

cytochrome P450, subfamily 2, polypeptide 11

decreases expression

Cephaloridine results in decreased expression of CYP2C mRNA

NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066

G

cytochrome P450 family 7 subfamily B member 1

increases expression

Cephaloridine results in increased expression of CYP7B1 mRNA

NCBI chr 2:100,502,791...100,669,713
Ensembl chr 2:100,502,791...100,669,698

G

dCTP pyrophosphatase 1

increases expression

Cephaloridine results in increased expression of DCTPP1 mRNA

NCBI chr 1:181,877,440...181,880,833
Ensembl chr 1:181,877,437...181,880,839

G

dCTP pyrophosphatase 1, pseudogene 2

increases expression

Cephaloridine results in increased expression of DCTPP1-PS2 mRNA

NCBI chr16:1,392,967...1,393,868

G

dopa decarboxylase

decreases expression

Cephaloridine results in decreased expression of DDC mRNA

NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208

G

DNA-damage-inducible transcript 4

decreases expression

Cephaloridine results in decreased expression of DDIT4 mRNA

NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105

G

DNA-damage-inducible transcript 4-like

increases expression

Cephaloridine results in increased expression of DDIT4L mRNA

NCBI chr 2:226,128,273...226,131,044
Ensembl chr 2:226,128,276...226,131,375

G

DExD-box helicase 39A

increases expression

Cephaloridine results in increased expression of DDX39A mRNA

NCBI chr19:24,418,743...24,427,422
Ensembl chr19:24,418,114...24,426,954

G

DEAD-box helicase 6

decreases expression

Cephaloridine results in decreased expression of DDX6 mRNA

NCBI chr 8:44,931,127...44,967,773
Ensembl chr 8:44,931,974...44,964,405
Ensembl chr 8:44,931,974...44,964,405

G

2,4-dienoyl-CoA reductase 2

decreases expression

Cephaloridine results in decreased expression of DECR2 mRNA

NCBI chr10:15,104,907...15,113,281
Ensembl chr10:15,002,926...15,118,479

G

dehydrogenase/reductase member 2 like 1

increases expression

Cephaloridine results in increased expression of DHRS2L1 mRNA

NCBI chr15:28,635,197...28,638,087
Ensembl chr15:28,635,197...28,638,087

G

DLG associated protein 1

increases expression

Cephaloridine results in increased expression of DLGAP1 mRNA

NCBI chr 9:109,857,500...110,726,817
Ensembl chr 9:110,167,448...110,726,817

G

dynein, axonemal, heavy chain 7

decreases expression

Cephaloridine results in decreased expression of DNAH7 mRNA

NCBI chr 9:54,960,235...55,266,529
Ensembl chr 9:54,960,440...55,262,297

G

dynein, axonemal, heavy chain 9

decreases expression

Cephaloridine results in decreased expression of DNAH9 mRNA

NCBI chr10:50,496,174...50,864,909
Ensembl chr10:50,497,688...50,864,949

G

deoxyribonuclease 1L3

increases expression

Cephaloridine results in increased expression of DNASE1L3 mRNA

NCBI chr15:16,922,335...16,948,322
Ensembl chr15:16,922,335...16,948,317

G

2'-deoxynucleoside 5'-phosphate N-hydrolase 1

increases expression

Cephaloridine results in increased expression of DNPH1 mRNA

NCBI chr 9:14,481,296...14,484,034
Ensembl chr 9:14,481,066...14,484,022

G

DNA replication fork stabilization factor DONSON

increases expression

Cephaloridine results in increased expression of DONSON mRNA

NCBI chr11:30,919,834...30,933,150
Ensembl chr11:30,923,239...30,932,889

G

double PHD fingers 1

increases expression

Cephaloridine results in increased expression of DPF1 mRNA

NCBI chr 1:84,602,212...84,615,954
Ensembl chr 1:84,602,336...84,615,950

G

DNA replication and sister chromatid cohesion 1

increases expression

Cephaloridine results in increased expression of DSCC1 mRNA

NCBI chr 7:86,482,588...86,498,212
Ensembl chr 7:86,482,588...86,498,212

G

desmoglein 2

increases expression

Cephaloridine results in increased expression of DSG2 mRNA

NCBI chr18:11,846,207...11,904,630
Ensembl chr18:11,846,183...11,904,156

G

deltex E3 ubiquitin ligase 4

increases expression

Cephaloridine results in increased expression of DTX4 mRNA

NCBI chr 1:209,457,719...209,545,163
Ensembl chr 1:209,460,735...209,492,818

G

dual specificity phosphatase 6

affects expression

Cephaloridine affects the expression of DUSP6 mRNA

NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185

G

dual specificity phosphatase 7

decreases expression

Cephaloridine results in decreased expression of DUSP7 mRNA

NCBI chr 8:107,009,369...107,016,404
Ensembl chr 8:107,008,528...107,016,404

G

dual specificity phosphatase 9

increases expression

Cephaloridine results in increased expression of DUSP9 mRNA

NCBI chr X:151,351,897...151,355,822
Ensembl chr X:151,351,897...151,355,821

G

E2F transcription factor 8

increases expression

Cephaloridine results in increased expression of E2F8 mRNA

NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098

G

erythroid differentiation regulatory factor 1

decreases expression

Cephaloridine results in decreased expression of EDRF1 mRNA

NCBI chr 1:188,441,514...188,478,743
Ensembl chr 1:188,441,634...188,478,701

G

eukaryotic translation elongation factor 2

increases expression

Cephaloridine results in increased expression of EEF2 mRNA

NCBI chr 7:8,533,248...8,538,518
Ensembl chr 7:8,533,116...8,559,183

G

early growth response 1

decreases expression

Cephaloridine results in decreased expression of EGR1 mRNA

NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766

G

early growth response 2

decreases expression

Cephaloridine results in decreased expression of EGR2 mRNA

NCBI chr20:21,051,270...21,056,322
Ensembl chr20:21,051,277...21,055,562

G

eukaryotic translation initiation factor 4H

increases expression

Cephaloridine results in increased expression of EIF4H mRNA

NCBI chr12:22,083,155...22,099,876
Ensembl chr12:22,082,835...22,099,876

G

E74 like ETS transcription factor 3

increases expression

Cephaloridine results in increased expression of ELF3 mRNA

NCBI chr13:46,690,460...46,695,394
Ensembl chr13:46,690,466...46,695,481

G

embigin

increases expression

Cephaloridine results in increased expression of EMB mRNA

NCBI chr 2:49,070,509...49,125,042
Ensembl chr 2:49,069,087...49,125,050

G

essential meiotic structure-specific endonuclease 1

decreases expression

Cephaloridine results in decreased expression of EME1 mRNA

NCBI chr10:79,586,718...79,595,515
Ensembl chr10:79,586,729...79,595,435

G

ectodermal-neural cortex 1

increases expression

Cephaloridine results in increased expression of ENC1 mRNA

NCBI chr 2:28,550,670...28,562,591
Ensembl chr 2:28,550,464...28,562,713

G

enolase 2

increases expression

Cephaloridine results in increased expression of ENO2 mRNA

NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980

G

endosomal transmembrane epsin interactor 1

increases expression

Cephaloridine results in increased expression of ENTREP1 mRNA

NCBI chr 1:221,592,500...221,646,603
Ensembl chr 1:221,592,503...221,646,758

G

extra spindle pole bodies like 1, separase

decreases expression

Cephaloridine results in decreased expression of ESPL1 mRNA

NCBI chr 7:133,424,027...133,450,984
Ensembl chr 7:133,424,130...133,450,984

G

exonuclease 1

increases expression

Cephaloridine results in increased expression of EXO1 mRNA

NCBI chr13:87,809,725...87,834,654
Ensembl chr13:87,809,810...87,834,654

G

coagulation factor XIII B chain

decreases expression

Cephaloridine results in decreased expression of F13B mRNA

NCBI chr13:51,130,908...51,156,383
Ensembl chr13:51,130,920...51,156,381

G

FAM111 trypsin like peptidase A

decreases expression

Cephaloridine results in decreased expression of FAM111A mRNA

NCBI chr 1:209,640,865...209,656,551
Ensembl chr 1:209,640,953...209,656,547

G

FA complementation group D2

increases expression

Cephaloridine results in increased expression of FANCD2 mRNA

NCBI chr 4:146,679,014...146,743,422
Ensembl chr 4:146,679,179...146,743,412

G

fibulin 1

increases expression

Cephaloridine results in increased expression of FBLN1 mRNA

NCBI chr 7:116,310,582...116,390,075
Ensembl chr 7:116,310,582...116,390,075

G

fructose-bisphosphatase 2

increases expression

Cephaloridine results in increased expression of FBP2 mRNA

NCBI chr17:2,236,088...2,253,702
Ensembl chr17:2,236,336...2,253,698

G

F-box protein 5

increases expression

Cephaloridine results in increased expression of FBXO5 mRNA

NCBI chr 1:42,196,068...42,202,437
Ensembl chr 1:42,196,068...42,202,437

G

Fc gamma receptor 2A

increases expression

Cephaloridine results in increased expression of FCGR2A mRNA

NCBI chr13:83,280,782...83,297,535
Ensembl chr13:83,280,784...83,295,967

G

Fc gamma receptor 2B

increases expression

Cephaloridine results in increased expression of FCGR2B mRNA

NCBI chr13:83,191,253...83,207,778
Ensembl chr13:83,193,163...83,207,778

G

Fc gamma receptor 3A

increases expression

Cephaloridine results in increased expression of FCGR3A mRNA

NCBI chr13:83,249,905...83,259,921
Ensembl chr13:83,249,872...83,259,921

G

ficolin B

increases expression

Cephaloridine results in increased expression of FCNB mRNA

NCBI chr 3:11,393,713...11,402,198
Ensembl chr 3:11,393,739...11,402,151

G

flap structure-specific endonuclease 1

increases expression

Cephaloridine results in increased expression of FEN1 mRNA

NCBI chr 1:206,845,126...206,849,821
Ensembl chr 1:206,844,884...206,850,003

G

fibrinogen beta chain

increases expression

Cephaloridine results in increased expression of FGB mRNA

NCBI chr 2:168,394,901...168,402,863
Ensembl chr 2:168,394,916...168,405,979

G

fibroblast growth factor 17

increases expression

Cephaloridine results in increased expression of FGF17 mRNA

NCBI chr15:45,711,498...45,717,622
Ensembl chr15:45,711,998...45,717,063

G

fibrinogen-like 2

increases expression

Cephaloridine results in increased expression of FGL2 mRNA

NCBI chr 4:13,710,566...13,716,207
Ensembl chr 4:13,710,575...13,716,207

G

FH2 domain containing 1

increases expression

Cephaloridine results in increased expression of FHDC1 mRNA

NCBI chr 2:169,790,917...169,829,580
Ensembl chr 2:169,790,947...169,827,896

G

filamin A interacting protein 1

decreases expression

Cephaloridine results in decreased expression of FILIP1 mRNA

NCBI chr 8:80,761,283...80,956,556
Ensembl chr 8:80,764,604...80,922,549

G

folate hydrolase 1

decreases expression

Cephaloridine results in decreased expression of FOLH1 mRNA

NCBI chr 1:140,428,101...140,501,563
Ensembl chr 1:140,428,101...140,501,379

G

Fos proto-oncogene, AP-1 transcription factor subunit

decreases expression

Cephaloridine results in decreased expression of FOS mRNA

NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036

G

forkhead box E1

decreases expression

Cephaloridine results in decreased expression of FOXE1 mRNA

NCBI chr 5:60,630,027...60,632,835
Ensembl chr 5:60,630,027...60,632,835

G

forkhead box Q1

increases expression

Cephaloridine results in increased expression of FOXQ1 mRNA

NCBI chr17:32,912,744...32,915,377
Ensembl chr17:32,912,744...32,915,377
Ensembl chr17:32,912,744...32,915,377

G

FYVE and coiled-coil domain autophagy adaptor 1

decreases expression

Cephaloridine results in decreased expression of FYCO1 mRNA

NCBI chr 8:123,412,105...123,479,315
Ensembl chr 8:123,412,112...123,479,021

G

glucose-6-phosphatase catalytic subunit 1

decreases expression

Cephaloridine results in decreased expression of G6PC1 mRNA

NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804

G

glucose-6-phosphate dehydrogenase

increases expression

Cephaloridine results in increased expression of G6PD mRNA

NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801

G

growth arrest and DNA-damage-inducible, alpha

increases expression

Cephaloridine results in increased expression of GADD45A mRNA

NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115

G

polypeptide N-acetylgalactosaminyltransferase 13

increases expression

Cephaloridine results in increased expression of GALNT13 mRNA

NCBI chr 3:38,903,695...39,560,683
Ensembl chr 3:38,974,490...39,558,803

G

glucosidase, alpha; neutral C

decreases expression

Cephaloridine results in decreased expression of GANC mRNA

NCBI chr 3:107,353,369...107,406,104
Ensembl chr 3:107,353,369...107,405,241

G

golgi associated RAB2 interactor family member 4

increases expression

Cephaloridine results in increased expression of GARIN4 mRNA

NCBI chr13:102,742,988...102,745,168
Ensembl chr13:102,742,988...102,745,168

G

glucosylceramidase beta 3

decreases expression

Cephaloridine results in decreased expression of GBA3 mRNA

NCBI chr14:60,574,974...60,721,411
Ensembl chr14:60,574,976...60,721,653

G

guanine deaminase

increases expression

Cephaloridine results in increased expression of GDA mRNA

NCBI chr 1:218,903,045...218,982,360
Ensembl chr 1:218,906,815...218,982,416

G

growth differentiation factor 15

decreases expression

Cephaloridine results in decreased expression of GDF15 mRNA

NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055

G

GDNF family receptor alpha 2

decreases expression

Cephaloridine results in decreased expression of GFRA2 mRNA

NCBI chr15:45,941,841...46,033,715
Ensembl chr15:45,941,828...46,033,714

G

GINS complex subunit 2

increases expression

Cephaloridine results in increased expression of GINS2 mRNA

NCBI chr19:48,626,770...48,639,523
Ensembl chr19:48,626,770...48,639,339

G

GINS complex subunit 4

increases expression

Cephaloridine results in increased expression of GINS4 mRNA

NCBI chr16:68,787,572...68,799,938
Ensembl chr16:68,767,339...68,802,273

G

geminin, DNA replication inhibitor

increases expression

Cephaloridine results in increased expression of GMNN mRNA

NCBI chr17:40,301,771...40,310,054
Ensembl chr17:40,301,808...40,310,054

G

G protein subunit alpha 14

increases expression

Cephaloridine results in increased expression of GNA14 mRNA

NCBI chr 1:213,714,993...213,900,083
Ensembl chr 1:213,716,020...213,897,423

G

glycoprotein nmb

increases expression

Cephaloridine results in increased expression of GPNMB mRNA

NCBI chr 4:78,010,247...78,031,491
Ensembl chr 4:78,010,197...78,049,367

G

G protein-coupled receptor 135

decreases expression

Cephaloridine results in decreased expression of GPR135 mRNA

NCBI chr 6:90,627,533...90,630,661
Ensembl chr 6:90,629,178...90,630,551

G

G protein-coupled receptor 19

increases expression

Cephaloridine results in increased expression of GPR19 mRNA

NCBI chr 4:167,710,944...167,739,232
Ensembl chr 4:167,710,666...167,741,036

G

glutathione peroxidase 2

increases expression

Cephaloridine results in increased expression of GPX2 mRNA

NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877

G

glutamate ionotropic receptor AMPA type subunit 3

decreases expression

Cephaloridine results in decreased expression of GRIA3 mRNA

NCBI chr X:120,238,515...120,504,106
Ensembl chr X:120,238,534...120,504,096

G

glutathione-disulfide reductase

increases expression

Cephaloridine results in increased expression of GSR mRNA

NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661

G

glutathione S-transferase alpha 2

increases expression

Cephaloridine results in increased expression of GSTA2 mRNA

NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798

G

glutathione S-transferase alpha 5

increases expression

Cephaloridine results in increased expression of GSTA5 mRNA

NCBI chr 8:79,105,561...79,117,472
Ensembl chr 8:79,105,661...79,117,472

G

glutathione S-transferase mu 1

increases expression

Cephaloridine results in increased expression of GSTM1 mRNA

PMID:18172885 PMID:18500788

NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411

G

glutathione S-transferase pi 1

increases expression

Cephaloridine results in increased expression of GSTP1 mRNA

NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226

G

glucoside xylosyltransferase 1

decreases expression

Cephaloridine results in decreased expression of GXYLT1 mRNA

NCBI chr 7:124,400,896...124,434,682
Ensembl chr 7:124,400,896...124,434,699

G

H1.1 linker histone, cluster member

increases expression

Cephaloridine results in increased expression of H1F1 mRNA

NCBI chr17:41,366,268...41,367,011
Ensembl chr17:41,366,268...41,367,011

G

hydroxyacyl-CoA dehydrogenase

decreases expression

Cephaloridine results in decreased expression of HADH mRNA

NCBI chr 2:219,787,935...219,830,335
Ensembl chr 2:219,787,927...219,830,353

G

HAUS augmin-like complex, subunit 8

increases expression

Cephaloridine results in increased expression of HAUS8 mRNA

NCBI chr16:17,930,819...17,945,254
Ensembl chr16:17,930,820...17,945,237

G

hepatitis A virus cellular receptor 1

increases expression

Cephaloridine results in increased expression of HAVCR1 mRNA

PMID:18500788 PMID:20305092

NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698

G

HCK proto-oncogene, Src family tyrosine kinase

increases expression

Cephaloridine results in increased expression of HCK mRNA

NCBI chr 3:141,571,587...141,614,696
Ensembl chr 3:141,571,587...141,614,693

G

heme binding protein 1

increases expression

Cephaloridine results in increased expression of HEBP1 mRNA

NCBI chr 4:167,974,316...168,003,854
Ensembl chr 4:167,974,319...168,003,854

G

heme binding protein 2

increases expression

Cephaloridine results in increased expression of HEBP2 mRNA

NCBI chr 1:13,194,982...13,201,777
Ensembl chr 1:13,194,982...13,201,777

G

helicase, lymphoid specific

increases expression

Cephaloridine results in increased expression of HELLS mRNA

NCBI chr 1:236,701,704...236,748,239
Ensembl chr 1:236,701,758...236,746,844

G

HEPACAM family member 2

increases expression

Cephaloridine results in increased expression of HEPACAM2 mRNA

NCBI chr 4:31,446,195...31,480,859
Ensembl chr 4:31,446,169...31,480,953

G

hemojuvelin BMP co-receptor

decreases expression

Cephaloridine results in decreased expression of HJV mRNA

NCBI chr 2:184,065,944...184,069,851
Ensembl chr 2:184,065,970...184,069,850

G

H2.0-like homeobox

decreases expression

Cephaloridine results in decreased expression of HLX mRNA

NCBI chr13:96,280,335...96,285,750
Ensembl chr13:96,280,339...96,285,750

G

3-hydroxy-3-methylglutaryl-CoA synthase 2

decreases expression

Cephaloridine results in decreased expression of HMGCS2 mRNA

NCBI chr 2:185,875,609...185,903,505
Ensembl chr 2:185,875,616...185,902,130

G

heme oxygenase 1

increases expression

Cephaloridine results in increased expression of HMOX1 mRNA

PMID:18172885 PMID:18500788

NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079

G

H6 family homeobox 3

increases expression

Cephaloridine results in increased expression of HMX3 mRNA

NCBI chr 1:186,313,237...186,315,201
Ensembl chr 1:186,313,063...186,315,201

G

heterogeneous nuclear ribonucleoprotein A1

increases expression

Cephaloridine results in increased expression of HNRNPA1 mRNA

NCBI chr 7:134,375,318...134,381,610
Ensembl chr 7:134,375,150...134,381,609

G

heterogeneous nuclear ribonucleoprotein A1, pseudogene 28

increases expression

Cephaloridine results in increased expression of HNRNPA1-PS28 mRNA

NCBI chr X:107,752,105...107,759,183

G

histidine-rich glycoprotein

decreases expression

Cephaloridine results in decreased expression of HRG mRNA

NCBI chr11:78,054,488...78,069,402
Ensembl chr11:78,054,498...78,069,389

G

hydroxysteroid (17-beta) dehydrogenase 2

decreases expression

Cephaloridine results in decreased expression of HSD17B2 mRNA

NCBI chr19:45,753,576...45,825,203
Ensembl chr19:45,753,574...45,825,202

G

hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1

increases expression

Cephaloridine results in increased expression of HSD3B1 mRNA

NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999

G

heat shock protein 90 alpha family class A member 1

increases expression

Cephaloridine results in increased expression of HSP90AA1 mRNA

NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268

G

heat shock protein family A (Hsp70) member 1A

increases expression

Cephaloridine results in increased expression of HSPA1A mRNA

NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227

G

heat shock protein family A (Hsp70) member 1B

increases expression

Cephaloridine results in increased expression of HSPA1B mRNA

NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240
Ensembl chr20:3,856,006...3,873,240

G

heat shock protein family H (Hsp110) member 1

increases expression

Cephaloridine results in increased expression of HSPH1 mRNA

NCBI chr12:5,390,916...5,410,224
Ensembl chr12:5,390,922...5,410,224

G

HIV-1 Tat interactive protein 2

increases expression

Cephaloridine results in increased expression of HTATIP2 mRNA

NCBI chr 1:99,473,411...99,488,632
Ensembl chr 1:99,469,245...99,488,629

G

5-hydroxytryptamine (serotonin) receptor 5B

increases expression

Cephaloridine results in increased expression of HTR5B mRNA

NCBI chr13:32,686,911...32,699,835
Ensembl chr13:32,687,042...32,699,835

G

intercellular adhesion molecule 1

increases expression

Cephaloridine results in increased expression of ICAM1 mRNA

NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438

G

isopentenyl-diphosphate delta isomerase 2 like 3

decreases expression

Cephaloridine results in decreased expression of IDI2L3 mRNA

NCBI chr17:61,518,138...61,535,484
Ensembl chr17:61,519,390...61,531,603

G

immediate early response 3

decreases expression

Cephaloridine results in decreased expression of IER3 mRNA

NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583

G

interferon induced transmembrane protein 10

increases expression

Cephaloridine results in increased expression of IFITM10 mRNA

NCBI chr 1:197,507,501...197,524,180
Ensembl chr 1:197,507,503...197,525,151

G

interleukin 18

increases expression

Cephaloridine results in increased expression of IL18 mRNA

NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887

G

interleukin 1 beta

decreases expression

Cephaloridine results in decreased expression of IL1B mRNA

NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415

G

interleukin 20 receptor subunit alpha

decreases expression

Cephaloridine results in decreased expression of IL20RA mRNA

NCBI chr 1:14,424,215...14,494,226
Ensembl chr 1:14,451,228...14,493,602

G

inhibin subunit beta B

decreases expression

Cephaloridine results in decreased expression of INHBB mRNA

NCBI chr13:30,530,860...30,536,566
Ensembl chr13:30,530,860...30,537,832

G

inositol-trisphosphate 3-kinase A

increases expression

Cephaloridine results in increased expression of ITPKA mRNA

NCBI chr 3:106,726,036...106,734,601
Ensembl chr 3:106,726,036...106,734,600

G

inositol-trisphosphate 3-kinase B

increases expression

Cephaloridine results in increased expression of ITPKB mRNA

NCBI chr13:92,069,160...92,164,281
Ensembl chr13:92,069,216...92,162,004

G

jade family PHD finger 2

decreases expression

Cephaloridine results in decreased expression of JADE2 mRNA

NCBI chr10:36,075,239...36,124,210
Ensembl chr10:36,078,917...36,116,984

G

Jun proto-oncogene, AP-1 transcription factor subunit

increases expression

Cephaloridine results in increased expression of JUN mRNA

NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656

G

JunB proto-oncogene, AP-1 transcription factor subunit

decreases expression
increases expression

Cephaloridine results in decreased expression of JUNB mRNA
Cephaloridine results in increased expression of JUNB mRNA

PMID:18172885 PMID:18500788

NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035

G

kelch repeat and BTB domain containing 11

decreases expression

Cephaloridine results in decreased expression of KBTBD11 mRNA

NCBI chr16:74,618,291...74,638,010
Ensembl chr16:74,615,792...74,637,736

G

potassium voltage-gated channel subfamily H member 1

increases expression

Cephaloridine results in increased expression of KCNH1 mRNA

NCBI chr13:103,722,140...104,024,762
Ensembl chr13:103,722,245...104,024,740

G

potassium inwardly-rectifying channel, subfamily J, member 15

decreases expression

Cephaloridine results in decreased expression of KCNJ15 mRNA

NCBI chr11:34,577,397...34,621,725
Ensembl chr11:34,577,363...34,621,952

G

potassium channel tetramerization domain containing 1

increases expression

Cephaloridine results in increased expression of KCTD1 mRNA

NCBI chr18:6,122,390...6,316,434
Ensembl chr18:6,122,390...6,317,393

G

alpha-ketoglutarate dehydrogenase subunit 4

increases expression

Cephaloridine results in increased expression of KGD4 mRNA

NCBI chr 2:31,870,549...31,878,335
Ensembl chr 2:31,870,551...31,880,730

G

kinesin family member 18A

decreases expression

Cephaloridine results in decreased expression of KIF18A mRNA

NCBI chr 3:95,764,388...95,824,756
Ensembl chr 3:95,764,388...95,824,582

G

kinesin family member 2C

decreases expression

Cephaloridine results in decreased expression of KIF2C mRNA

NCBI chr 5:130,637,347...130,662,680
Ensembl chr 5:130,637,347...130,662,637

G

KLF transcription factor 7

decreases expression

Cephaloridine results in decreased expression of KLF7 mRNA

NCBI chr 9:65,433,683...65,526,372
Ensembl chr 9:65,437,167...65,526,261

G

kelch-like family member 25

decreases expression

Cephaloridine results in decreased expression of KLHL25 mRNA

NCBI chr 1:129,724,894...129,750,142
Ensembl chr 1:129,722,026...129,750,227

G

kinetochore-localized astrin/SPAG5 binding protein

decreases expression

Cephaloridine results in decreased expression of KNSTRN mRNA

NCBI chr 3:105,800,762...105,820,555
Ensembl chr 3:105,800,954...105,820,715

G

kinetochore associated 1

increases expression

Cephaloridine results in increased expression of KNTC1 mRNA

NCBI chr12:32,769,020...32,839,617
Ensembl chr12:32,769,020...32,839,561

G

laminin subunit alpha 2

decreases expression

Cephaloridine results in decreased expression of LAMA2 mRNA

NCBI chr 1:17,672,675...18,320,641
Ensembl chr 1:17,672,536...18,320,530

G

laminin subunit beta 3

increases expression

Cephaloridine results in increased expression of LAMB3 mRNA

NCBI chr13:104,833,810...104,875,405
Ensembl chr13:104,833,873...104,875,405

G

leucyl-tRNA synthetase 1

decreases expression

Cephaloridine results in decreased expression of LARS1 mRNA

NCBI chr18:34,201,555...34,256,003
Ensembl chr18:34,201,549...34,255,931

G

ligand dependent nuclear receptor corepressor

decreases expression

Cephaloridine results in decreased expression of LCOR mRNA

NCBI chr 1:240,298,565...240,405,627
Ensembl chr 1:240,298,563...240,402,448

G

leukocyte cell-derived chemotaxin 2

decreases expression

Cephaloridine results in decreased expression of LECT2 mRNA

NCBI chr17:8,044,759...8,050,983
Ensembl chr17:8,044,759...8,050,983

G

galectin 2

increases expression

Cephaloridine results in increased expression of LGALS2 mRNA

NCBI chr 7:110,403,171...110,410,046
Ensembl chr 7:110,403,173...110,404,802

G

galectin 3

increases expression

Cephaloridine results in increased expression of LGALS3 mRNA

NCBI chr15:20,620,083...20,632,019
Ensembl chr15:20,607,692...20,632,025

G

LIM homeobox 3

decreases expression

Cephaloridine results in decreased expression of LHX3 mRNA

NCBI chr 3:9,026,432...9,035,122
Ensembl chr 3:9,027,425...9,034,480

G

DNA ligase 1

increases expression

Cephaloridine results in increased expression of LIG1 mRNA

NCBI chr 1:74,165,688...74,204,400
Ensembl chr 1:74,165,842...74,204,413

G

lamin B1

decreases expression

Cephaloridine results in decreased expression of LMNB1 mRNA

NCBI chr18:50,175,861...50,215,210
Ensembl chr18:50,175,874...50,214,502

G

LRAT domain containing 1

increases expression

Cephaloridine results in increased expression of LRATD1 mRNA

NCBI chr 6:36,916,969...36,922,143
Ensembl chr 6:36,913,469...36,922,319

G

leucine rich repeat neuronal 3

decreases expression

Cephaloridine results in decreased expression of LRRN3 mRNA

NCBI chr 6:58,489,060...58,520,322
Ensembl chr 6:58,489,010...58,520,330

G

MAF bZIP transcription factor

decreases expression

Cephaloridine results in decreased expression of MAF mRNA

NCBI chr19:43,353,867...43,713,162
Ensembl chr19:43,360,342...43,712,365

G

mitogen-activated protein kinase kinase kinase 1

increases expression

Cephaloridine results in increased expression of MAP3K1 mRNA

NCBI chr 2:43,348,572...43,414,706
Ensembl chr 2:43,350,098...43,414,463

G

mitogen activated protein kinase kinase kinase 12

decreases expression

Cephaloridine results in decreased expression of MAP3K12 mRNA

NCBI chr 7:133,630,267...133,648,464
Ensembl chr 7:133,630,835...133,640,789

G

mitogen activated protein kinase 1

multiple interactions
increases phosphorylation
increases activity

Thymic Factor, Circulating inhibits the reaction [Cephaloridine results in increased phosphorylation of MAPK1 protein]
Cephaloridine results in increased activity of MAPK1 protein

PMID:16154539 PMID:16272694

NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616

G

mitogen activated protein kinase 3

increases activity
multiple interactions
increases phosphorylation

Cephaloridine results in increased activity of MAPK3 protein
Thymic Factor, Circulating inhibits the reaction [Cephaloridine results in increased phosphorylation of MAPK3 protein]

PMID:16154539 PMID:16272694

NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863

G

mitogen-activated protein kinase 8 interacting protein 3

increases expression

Cephaloridine results in increased expression of MAPK8IP3 mRNA

NCBI chr10:13,918,417...13,958,335
Ensembl chr10:13,918,400...13,958,273

G

MBL associated serine protease 2

increases expression

Cephaloridine results in increased expression of MASP2 mRNA

NCBI chr 5:159,035,892...159,049,561
Ensembl chr 5:159,035,911...159,049,580

G

minichromosome maintenance complex component 2

increases expression

Cephaloridine results in increased expression of MCM2 mRNA

NCBI chr 4:121,346,434...121,360,962
Ensembl chr 4:121,346,434...121,360,847

G

minichromosome maintenance complex component 3

increases expression

Cephaloridine results in increased expression of MCM3 mRNA

NCBI chr 9:23,219,169...23,237,314
Ensembl chr 9:23,219,169...23,237,314

G

minichromosome maintenance complex component 5

increases expression

Cephaloridine results in increased expression of MCM5 mRNA

NCBI chr19:13,483,030...13,504,389
Ensembl chr19:13,483,066...13,504,389

G

minichromosome maintenance complex component 6

increases expression

Cephaloridine results in increased expression of MCM6 mRNA

NCBI chr13:39,826,745...39,851,937
Ensembl chr13:39,826,763...39,851,960

G

minichromosome maintenance complex component 7

increases expression

Cephaloridine results in increased expression of MCM7 mRNA

NCBI chr12:17,042,207...17,049,470
Ensembl chr12:17,042,212...17,050,063

G

minichromosome maintenance 8 homologous recombination repair factor

increases expression

Cephaloridine results in increased expression of MCM8 mRNA

NCBI chr 3:120,086,741...120,117,008
Ensembl chr 3:120,086,763...120,117,008

G

mesoderm posterior bHLH transcription factor 1

decreases expression

Cephaloridine results in decreased expression of MESP1 mRNA

NCBI chr 1:133,738,357...133,739,875
Ensembl chr 1:133,738,357...133,739,875

G

MET proto-oncogene, receptor tyrosine kinase

increases expression

Cephaloridine results in increased expression of MET mRNA

NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876

G

monoglyceride lipase

decreases expression

Cephaloridine results in decreased expression of MGLL mRNA

NCBI chr 4:121,192,186...121,294,187
Ensembl chr 4:121,192,195...121,294,179

G

marker of proliferation Ki-67

decreases expression

Cephaloridine results in decreased expression of MKI67 mRNA

NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762

G

matrix metallopeptidase 12

increases expression

Cephaloridine results in increased expression of MMP12 mRNA

NCBI chr 8:4,581,785...4,591,687
Ensembl chr 8:4,581,785...4,599,611

G

matrix metallopeptidase 16

increases expression

Cephaloridine results in increased expression of MMP16 mRNA

NCBI chr 5:31,312,280...31,556,276
Ensembl chr 5:31,312,280...31,548,388

G

meiotic nuclear divisions 1

increases expression

Cephaloridine results in increased expression of MND1 mRNA

NCBI chr 2:169,433,523...169,496,081
Ensembl chr 2:169,433,540...169,496,096

G

meiosis-specific nuclear structural 1

decreases expression

Cephaloridine results in decreased expression of MNS1 mRNA

NCBI chr 8:73,148,877...73,169,570
Ensembl chr 8:73,148,877...73,176,925

G

mercaptopyruvate sulfurtransferase

decreases expression

Cephaloridine results in decreased expression of MPST mRNA

NCBI chr 7:109,955,581...109,963,155
Ensembl chr 7:109,955,675...109,963,141

G

MPV17 mitochondrial inner membrane protein like

decreases expression

Cephaloridine results in decreased expression of MPV17L mRNA

NCBI chr10:1,988,451...2,025,300
Ensembl chr10:1,988,136...2,007,649

G

metallothionein 1

decreases expression

Cephaloridine results in decreased expression of MT1A mRNA

NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049
Ensembl chr17:10,826,032...10,827,049
Ensembl chr X:10,826,032...10,827,049

G

methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like

increases expression

Cephaloridine results in increased expression of MTHFD1L mRNA

NCBI chr 1:40,443,926...40,632,911
Ensembl chr 1:40,444,008...40,632,905

G

methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase

increases expression

Cephaloridine results in increased expression of MTHFD2 mRNA

NCBI chr 4:115,811,135...115,822,663
Ensembl chr 4:115,811,139...115,822,608

G

myomesin 3

increases expression

Cephaloridine results in increased expression of MYOM3 mRNA

NCBI chr 5:147,992,737...148,043,282
Ensembl chr 5:147,992,737...148,043,274

G

nuclear receptor co-repressor 2

decreases expression

Cephaloridine results in decreased expression of NCOR2 mRNA

NCBI chr12:31,466,418...31,628,319
Ensembl chr12:31,466,412...31,628,319

G

NIMA-related kinase 6

increases expression

Cephaloridine results in increased expression of NEK6 mRNA

NCBI chr 3:22,284,269...22,356,302
Ensembl chr 3:22,284,279...22,395,990

G

nuclear factor, interleukin 3 regulated

increases expression

Cephaloridine results in increased expression of NFIL3 mRNA

NCBI chr17:12,280,499...12,295,728
Ensembl chr17:12,280,484...12,295,858

G

NFKB inhibitor alpha

decreases expression

Cephaloridine results in decreased expression of NFKBIA mRNA

NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941

G

NFKB inhibitor zeta

decreases expression

Cephaloridine results in decreased expression of NFKBIZ mRNA

NCBI chr11:44,782,676...44,810,722
Ensembl chr11:44,782,676...44,810,723

G

nerve growth factor receptor

increases expression

Cephaloridine results in increased expression of NGFR mRNA

NCBI chr10:80,515,287...80,533,518
Ensembl chr10:80,515,299...80,533,518

G

NHP2 ribonucleoprotein

increases expression

Cephaloridine results in increased expression of NHP2 mRNA

NCBI chr10:35,877,057...35,880,399
Ensembl chr10:35,877,054...35,882,545

G

ninjurin 2

increases expression

Cephaloridine results in increased expression of NINJ2 mRNA

NCBI chr 4:153,306,439...153,408,618
Ensembl chr 4:153,306,553...153,408,617

G

nipsnap homolog 3A (C. elegans)

increases expression

Cephaloridine results in increased expression of NIPSNAP3B mRNA

NCBI chr 5:67,613,993...67,625,067
Ensembl chr 5:67,614,036...67,669,700

G

NME/NM23 nucleoside diphosphate kinase 4

decreases expression

Cephaloridine results in decreased expression of NME4 mRNA

NCBI chr10:15,114,624...15,118,479
Ensembl chr10:15,002,926...15,118,479

G

NOP56 ribonucleoprotein

increases expression

Cephaloridine results in increased expression of NOP56 mRNA

NCBI chr 3:117,476,963...117,481,847
Ensembl chr 3:117,477,053...117,481,841

G

NAD(P)H quinone dehydrogenase 1

increases expression

Cephaloridine results in increased expression of NQO1 mRNA

PMID:18172885 PMID:18500788

NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557

G

nuclear receptor subfamily 1, group D, member 1

increases expression

Cephaloridine results in increased expression of NR1D1 mRNA

NCBI chr10:83,728,348...83,735,562
Ensembl chr10:83,728,318...83,735,705

G

nurim

increases expression

Cephaloridine results in increased expression of NRM mRNA

NCBI chr20:2,888,321...2,892,804
Ensembl chr20:2,877,567...2,891,802

G

nudix hydrolase 11

increases expression

Cephaloridine results in increased expression of NUDT10 mRNA; Cephaloridine results in increased expression of NUDT11 mRNA

NCBI chr X:16,326,775...16,333,396
Ensembl chr X:16,326,598...16,333,145

G

opioid related nociceptin receptor 1

increases expression

Cephaloridine results in increased expression of OPRL1 mRNA

NCBI chr 3:168,831,934...168,839,920
Ensembl chr 3:168,834,003...168,839,920

G

olfactory receptor family 2 subfamily W member 6

increases expression

Cephaloridine results in increased expression of OR2W6 mRNA

NCBI chr17:42,906,458...42,907,396
Ensembl chr17:42,904,951...42,919,599

G

olfactory receptor family 52 subfamily B member 2

increases expression

Cephaloridine results in increased expression of OR52B2 mRNA

NCBI chr 1:159,695,507...159,696,475
Ensembl chr 1:159,694,964...159,701,227

G

olfactory receptor family 52 subfamily K member 1

decreases expression

Cephaloridine results in decreased expression of OR52K1 mRNA

NCBI chr 1:157,037,381...157,038,325
Ensembl chr 1:157,037,381...157,038,325

G

origin recognition complex, subunit 6

increases expression

Cephaloridine results in increased expression of ORC6 mRNA

NCBI chr19:21,757,867...21,765,638
Ensembl chr19:21,757,866...21,765,662

G

oxysterol binding protein-like 8

decreases expression

Cephaloridine results in decreased expression of OSBPL8 mRNA

NCBI chr 7:46,596,944...46,749,888
Ensembl chr 7:46,596,983...46,749,888

G

oncostatin M receptor

increases expression

Cephaloridine results in increased expression of OSMR mRNA

NCBI chr 2:55,907,119...55,961,373
Ensembl chr 2:55,907,132...55,961,262

G

oxoglutarate receptor 1

increases expression

Cephaloridine results in increased expression of OXGR1 mRNA

NCBI chr15:97,145,947...97,146,960
Ensembl chr15:97,144,293...97,166,612

G

peptidyl arginine deiminase 6

increases expression

Cephaloridine results in increased expression of PADI6 mRNA

NCBI chr 5:153,021,855...153,037,443
Ensembl chr 5:153,021,965...153,037,414

G

partner and localizer of BRCA2

increases expression

Cephaloridine results in increased expression of PALB2 mRNA

NCBI chr 1:176,665,076...176,689,053
Ensembl chr 1:176,665,076...176,688,990

G

PAS domain containing serine/threonine kinase

increases expression

Cephaloridine results in increased expression of PASK mRNA

NCBI chr 9:93,844,275...93,886,036
Ensembl chr 9:93,844,278...93,885,111

G

PDZ binding kinase

decreases expression

Cephaloridine results in decreased expression of PBK mRNA

NCBI chr15:40,022,873...40,034,014
Ensembl chr15:40,023,002...40,034,014

G

protocadherin 7

decreases expression

Cephaloridine results in decreased expression of PCDH7 mRNA

NCBI chr14:52,471,801...52,901,696
Ensembl chr14:52,475,610...52,902,051
Ensembl chr14:52,475,610...52,902,051

G

protocadherin 9

decreases expression

Cephaloridine results in decreased expression of PCDH9 mRNA

NCBI chr15:69,340,108...70,237,531
Ensembl chr15:69,340,645...70,237,538

G

phosphoenolpyruvate carboxykinase 1

decreases expression

Cephaloridine results in decreased expression of PCK1 mRNA

NCBI chr 3:161,930,256...161,936,205
Ensembl chr 3:161,930,256...161,936,191

G

PCNA clamp associated factor

increases expression

Cephaloridine results in increased expression of PCLAF mRNA

NCBI chr 8:66,420,606...66,432,994
Ensembl chr 8:66,420,587...66,432,994
Ensembl chr 8:66,420,587...66,432,994

G

proliferating cell nuclear antigen

increases expression

Cephaloridine results in increased expression of PCNA mRNA

NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995

G

protein disulfide isomerase family A, member 4

increases expression

Cephaloridine results in increased expression of PDIA4 mRNA

NCBI chr 4:76,803,198...76,822,245
Ensembl chr 4:76,803,198...76,822,107

G

profilin 3

decreases expression

Cephaloridine results in decreased expression of PFN3 mRNA

NCBI chr17:9,217,595...9,218,122

G

pipecolic acid and sarcosine oxidase

increases expression

Cephaloridine results in increased expression of PIPOX mRNA

NCBI chr10:62,769,874...62,783,484
Ensembl chr10:62,769,900...62,782,370

G

pirin

increases expression

Cephaloridine results in increased expression of PIR mRNA

NCBI chr X:30,108,536...30,219,269
Ensembl chr X:30,108,538...30,219,218

G

PKHD1 ciliary IPT domain containing fibrocystin/polyductin

decreases expression

Cephaloridine results in decreased expression of PKHD1 mRNA

NCBI chr 9:22,547,396...23,037,443
Ensembl chr 9:22,549,513...23,037,381

G

protein kinase, membrane associated tyrosine/threonine 1

increases expression

Cephaloridine results in increased expression of PKMYT1 mRNA

NCBI chr10:12,748,221...12,758,995
Ensembl chr10:12,748,237...12,758,995

G

phospholipase A1 member A

increases expression

Cephaloridine results in increased expression of PLA1A mRNA

NCBI chr11:62,320,112...62,357,779
Ensembl chr11:62,320,493...62,357,779

G

pleckstrin 2

increases expression

Cephaloridine results in increased expression of PLEK2 mRNA

NCBI chr 6:97,700,123...97,719,417
Ensembl chr 6:97,701,106...97,719,326

G

pleckstrin homology domain containing A5

decreases expression

Cephaloridine results in decreased expression of PLEKHA5 mRNA

NCBI chr 4:173,333,891...173,503,546
Ensembl chr 4:173,334,055...173,503,546

G

polo-like kinase 1

decreases expression

Cephaloridine results in decreased expression of PLK1 mRNA

NCBI chr 1:176,716,420...176,726,400
Ensembl chr 1:176,716,420...176,726,400

G

DNA polymerase alpha 2, accessory subunit

increases expression

Cephaloridine results in increased expression of POLA2 mRNA

NCBI chr 1:203,227,183...203,251,350
Ensembl chr 1:203,203,388...203,251,348

G

DNA polymerase delta 1, catalytic subunit

increases expression

Cephaloridine results in increased expression of POLD1 mRNA

NCBI chr 1:95,025,462...95,041,559
Ensembl chr 1:95,025,499...95,036,465

G

DNA polymerase epsilon, catalytic subunit

increases expression

Cephaloridine results in increased expression of POLE mRNA

NCBI chr12:46,345,420...46,393,984
Ensembl chr12:46,345,420...46,393,939

G

inorganic pyrophosphatase 1

increases expression

Cephaloridine results in increased expression of PPA1 mRNA

NCBI chr20:29,590,733...29,617,711
Ensembl chr20:29,590,707...29,619,215

G

protein phosphatase, Mg2+/Mn2+ dependent, 1J

increases expression

Cephaloridine results in increased expression of PPM1J mRNA

NCBI chr 2:192,278,597...192,283,883
Ensembl chr 2:192,278,517...192,283,882

G

protein phosphatase 1, regulatory subunit 15A

decreases expression

Cephaloridine results in decreased expression of PPP1R15A mRNA

NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171

G

protein regulator of cytokinesis 1

decreases expression

Cephaloridine results in decreased expression of PRC1 mRNA

NCBI chr 1:134,250,086...134,271,765
Ensembl chr 1:134,250,081...134,271,765

G

DNA primase subunit 1

increases expression

Cephaloridine results in increased expression of PRIM1 mRNA

NCBI chr 7:446,342...462,526
Ensembl chr 7:431,805...462,526

G

protein kinase cAMP-dependent type I regulatory subunit beta

increases expression

Cephaloridine results in increased expression of PRKAR1B mRNA

NCBI chr12:15,492,233...15,624,942
Ensembl chr12:15,511,801...15,624,942

G

proline dehydrogenase 2

decreases expression

Cephaloridine results in decreased expression of PRODH2 mRNA

NCBI chr 1:85,753,558...85,767,165
Ensembl chr 1:85,753,644...85,767,162

G

paired related homeobox 1

decreases expression

Cephaloridine results in decreased expression of PRRX1 mRNA

NCBI chr13:75,600,777...75,671,896
Ensembl chr13:75,601,706...75,670,866

G

serine protease 35

decreases expression

Cephaloridine results in decreased expression of PRSS35 mRNA

NCBI chr 8:87,714,449...87,731,009
Ensembl chr 8:87,714,966...87,731,009

G

proteasome 20S subunit beta 4

increases expression

Cephaloridine results in increased expression of PSMB4 mRNA

NCBI chr 2:182,442,757...182,445,532
Ensembl chr 2:182,442,756...182,445,746

G

polypyrimidine tract binding protein 1

increases expression

Cephaloridine results in increased expression of PTBP1 mRNA

NCBI chr 7:9,842,574...9,852,332
Ensembl chr 7:9,842,574...9,852,397

G

prostaglandin reductase 1

increases expression

Cephaloridine results in increased expression of PTGR1 mRNA

NCBI chr 5:73,784,000...73,802,624
Ensembl chr 5:73,784,009...73,802,666

G

protein tyrosine phosphatase, non-receptor type 11

decreases expression

Cephaloridine results in decreased expression of PTPN11 mRNA

NCBI chr12:35,365,436...35,424,925
Ensembl chr12:35,383,144...35,424,925

G

protein tyrosine phosphatase, receptor type, B

decreases expression

Cephaloridine results in decreased expression of PTPRB mRNA

NCBI chr 7:51,953,375...52,034,751
Ensembl chr 7:51,930,015...52,034,748

G

protein tyrosine phosphatase, receptor type N2

increases expression

Cephaloridine results in increased expression of PTPRN2 mRNA

NCBI chr 6:137,439,572...138,191,575
Ensembl chr 6:137,439,540...138,191,575

G

peptidyl-tRNA hydrolase 1 homolog

increases expression

Cephaloridine results in increased expression of PTRH1 mRNA

NCBI chr 3:16,064,867...16,071,098
Ensembl chr 3:16,064,880...16,070,648

G

PVR cell adhesion molecule

increases expression

Cephaloridine results in increased expression of PVR mRNA

NCBI chr 1:79,561,294...79,576,700
Ensembl chr 1:79,546,879...79,576,715

G

RAB11 family interacting protein 3

decreases expression

Cephaloridine results in decreased expression of RAB11FIP3 mRNA

NCBI chr10:15,002,650...15,086,382
Ensembl chr10:15,002,926...15,118,479

G

RAB31, member RAS oncogene family

decreases expression

Cephaloridine results in decreased expression of RAB31 mRNA

NCBI chr 9:105,246,712...105,382,973
Ensembl chr 9:105,246,709...105,381,253

G

RAD18 E3 ubiquitin protein ligase

increases expression

Cephaloridine results in increased expression of RAD18 mRNA

NCBI chr 4:145,735,654...145,821,102
Ensembl chr 4:145,735,654...145,821,069

G

RB transcriptional corepressor 1

affects activity

Cephaloridine affects the activity of RB1 protein

NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302

G

retinol binding protein 2

increases expression

Cephaloridine results in increased expression of RBP2 mRNA

NCBI chr 8:99,079,293...99,104,489
Ensembl chr 8:99,079,104...99,104,473

G

rabenosyn, RAB effector

decreases expression

Cephaloridine results in decreased expression of RBSN mRNA

NCBI chr 4:124,682,228...124,712,578
Ensembl chr 4:124,683,969...124,712,578

G

retinol dehydrogenase 16

decreases expression

Cephaloridine results in decreased expression of RDH2 mRNA

NCBI chr 7:63,616,711...63,625,053
Ensembl chr 7:63,597,536...63,624,124

G

RecQ like helicase 4

increases expression

Cephaloridine results in increased expression of RECQL4 mRNA

NCBI chr 7:108,423,453...108,430,790
Ensembl chr 7:108,423,455...108,430,619

G

RELA proto-oncogene, NF-kB subunit

affects activity

Cephaloridine affects the activity of RELA protein

NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484

G

replication factor C subunit 3

increases expression

Cephaloridine results in increased expression of RFC3 mRNA

NCBI chr12:1,000,987...1,011,778
Ensembl chr12:1,000,994...1,011,778

G

replication factor C subunit 4

increases expression

Cephaloridine results in increased expression of RFC4 mRNA

NCBI chr11:77,749,642...77,764,123
Ensembl chr11:77,749,638...77,764,122

G

regucalcin

decreases expression

Cephaloridine results in decreased expression of RGN mRNA

PMID:8584014 PMID:18500788

NCBI chr X:1,619,030...1,634,456
Ensembl chr X:1,619,032...1,634,450

G

regulator of G-protein signaling 11

increases expression

Cephaloridine results in increased expression of RGS11 mRNA

NCBI chr10:15,222,804...15,231,062
Ensembl chr10:15,222,803...15,231,060

G

Rh family, C glycoprotein

increases expression

Cephaloridine results in increased expression of RHCG mRNA

NCBI chr 1:133,531,704...133,555,902
Ensembl chr 1:133,531,716...133,555,876

G

Rho-related BTB domain containing 1

decreases expression

Cephaloridine results in decreased expression of RHOBTB1 mRNA

NCBI chr20:19,327,142...19,456,121
Ensembl chr20:19,327,155...19,403,012

G

rhophilin, Rho GTPase binding protein 2

increases expression

Cephaloridine results in increased expression of RHPN2 mRNA

NCBI chr 1:87,991,143...88,051,895
Ensembl chr 1:87,991,144...88,051,902

G

reactive intermediate imine deaminase A homolog

decreases expression

Cephaloridine results in decreased expression of RIDA mRNA

NCBI chr 7:65,691,429...65,705,257
Ensembl chr 7:65,691,435...65,705,716

G

Rho family GTPase 1

increases expression

Cephaloridine results in increased expression of RND1 mRNA

NCBI chr 7:129,821,311...129,828,385
Ensembl chr 7:129,821,311...129,828,399

G

ring finger protein 227

increases expression

Cephaloridine results in increased expression of RNF227 mRNA

NCBI chr10:54,061,054...54,063,015
Ensembl chr10:54,059,947...54,063,010

G

ribosomal protein L23A

increases expression

Cephaloridine results in increased expression of RPL23A mRNA

NCBI chr10:63,076,660...63,079,346
Ensembl chr10:63,076,066...63,079,346
Ensembl chr15:63,076,066...63,079,346

G

ribosomal protein L23A like 1

increases expression

Cephaloridine results in increased expression of RPL23AL1 mRNA

NCBI chr 2:38,452,814...38,453,384
Ensembl chr 2:38,451,401...38,453,417

G

ribosomal protein L32 like 4

decreases expression

Cephaloridine results in decreased expression of RPL32L4 mRNA

NCBI chr 8:84,691,128...84,692,042

G

ribonucleotide reductase regulatory subunit M2

decreases expression

Cephaloridine results in decreased expression of RRM2 mRNA

NCBI chr 6:41,339,858...41,346,774
Ensembl chr 6:41,340,557...41,346,773

G

RUNX1 partner transcriptional co-repressor 1

decreases expression

Cephaloridine results in decreased expression of RUNX1T1 mRNA

NCBI chr 5:27,187,674...27,338,070
Ensembl chr 5:27,187,551...27,335,592

G

retinoid X receptor gamma

increases expression

Cephaloridine results in increased expression of RXRG mRNA

NCBI chr13:79,743,430...79,785,173
Ensembl chr13:79,743,563...79,785,167

G

secretoglobin, family 3A, member 1

increases expression

Cephaloridine results in increased expression of SCGB3A1 mRNA

NCBI chr10:33,968,059...33,969,366
Ensembl chr10:33,968,059...33,969,476

G

secretoglobin, family 3A, member 2

increases expression

Cephaloridine results in increased expression of SCGB3A2 mRNA

NCBI chr18:35,932,840...35,935,762
Ensembl chr18:35,932,840...35,935,762

G

secretin

increases expression

Cephaloridine results in increased expression of SCT mRNA

NCBI chr 1:196,382,857...196,383,668
Ensembl chr 1:196,382,856...196,383,658

G

secreted and transmembrane 1B

increases expression

Cephaloridine results in increased expression of SECTM1A mRNA

NCBI chr10:106,324,070...106,333,779
Ensembl chr10:106,325,203...106,333,769

G

selenoprotein P

decreases expression

Cephaloridine results in decreased expression of SELENOP mRNA

NCBI chr 2:52,498,123...52,508,409
Ensembl chr 2:52,498,339...52,508,852

G

semaphorin 4C

decreases expression

Cephaloridine results in decreased expression of SEMA4C mRNA

NCBI chr 9:38,791,668...38,802,171
Ensembl chr 9:38,791,670...38,802,128

G

septin 10

decreases expression

Cephaloridine results in decreased expression of SEPTIN10 mRNA

NCBI chr20:27,101,764...27,194,997
Ensembl chr20:27,101,752...27,194,780

G

SH2B adaptor protein 2

increases expression

Cephaloridine results in increased expression of SH2B2 mRNA

NCBI chr12:20,427,057...20,456,845
Ensembl chr12:20,429,043...20,456,844

G

SH3-domain binding protein 2

increases expression

Cephaloridine results in increased expression of SH3BP2 mRNA

NCBI chr14:76,176,097...76,213,300
Ensembl chr14:76,176,101...76,213,251

G

shroom family member 4

decreases expression

Cephaloridine results in decreased expression of SHROOM4 mRNA

NCBI chr X:15,869,065...16,076,850
Ensembl chr X:15,869,065...16,076,869

G

sialic acid binding Ig-like lectin 5

increases expression

Cephaloridine results in increased expression of SIGLEC5 mRNA

NCBI chr 1:93,768,190...93,776,696
Ensembl chr 1:93,768,319...93,776,694

G

spindle and kinetochore associated complex subunit 1

decreases expression

Cephaloridine results in decreased expression of SKA1 mRNA

NCBI chr18:67,794,722...67,805,037
Ensembl chr18:67,794,725...67,805,037

G

solute carrier family 15 member 3

increases expression

Cephaloridine results in increased expression of SLC15A3 mRNA

NCBI chr 1:207,492,365...207,507,158
Ensembl chr 1:207,492,365...207,507,157

G

solute carrier family 16, member 12

decreases expression

Cephaloridine results in decreased expression of SLC16A12 mRNA

NCBI chr 1:232,184,004...232,262,170
Ensembl chr 1:232,185,907...232,262,141

G

solute carrier family 16, member 14

decreases expression

Cephaloridine results in decreased expression of SLC16A14 mRNA

NCBI chr 9:86,110,066...86,137,546
Ensembl chr 9:86,112,894...86,137,318

G

solute carrier family 1 member 5

increases expression

Cephaloridine results in increased expression of SLC1A5 mRNA

NCBI chr 1:77,456,849...77,470,952
Ensembl chr 1:77,456,694...77,470,952

G

solute carrier family 22, member 23

decreases expression

Cephaloridine results in decreased expression of SLC22A23 mRNA

NCBI chr17:30,544,106...30,709,790
Ensembl chr17:30,544,106...30,709,790

G

solute carrier family 22 member 5

decreases expression

Cephaloridine results in decreased expression of SLC22A5 mRNA

NCBI chr10:38,008,303...38,035,474
Ensembl chr10:38,008,311...38,035,309

G

solute carrier family 22 member 6

increases import
multiple interactions
increases uptake

SLC22A6 protein results in increased import of Cephaloridine
Cephaloridine inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid]
SLC22A6 protein results in increased uptake of Cephaloridine

PMID:10594788 PMID:16098483

NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173

G

solute carrier family 22 member 8

increases uptake
multiple interactions

SLC22A8 protein results in increased uptake of Cephaloridine
Cephaloridine inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]

NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450

G

solute carrier family 35 member D2

increases expression

Cephaloridine results in increased expression of SLC35D2 mRNA

NCBI chr17:987,899...1,019,747
Ensembl chr17:988,157...1,019,743

G

solute carrier family 39 member 4

increases expression

Cephaloridine results in increased expression of SLC39A4 mRNA

NCBI chr 7:108,333,368...108,337,553
Ensembl chr 7:108,333,381...108,337,553

G

solute carrier family 41 member 2

increases expression

Cephaloridine results in increased expression of SLC41A2 mRNA

NCBI chr 7:20,383,714...20,491,178
Ensembl chr 7:20,383,757...20,491,166

G

solute carrier family 46, member 3

increases expression

Cephaloridine results in increased expression of SLC46A3 mRNA

NCBI chr12:7,140,610...7,157,093
Ensembl chr12:7,140,668...7,157,092

G

solute carrier family 4 member 4

decreases expression

Cephaloridine results in decreased expression of SLC4A4 mRNA

NCBI chr14:18,841,289...19,293,297
Ensembl chr14:18,845,159...19,272,883

G

solute carrier family 5 member 3

increases expression

Cephaloridine results in increased expression of SLC5A3 mRNA

NCBI chr11:31,313,847...31,316,293
Ensembl chr11:31,295,476...31,318,883

G

solute carrier family 7 member 10

increases expression

Cephaloridine results in increased expression of SLC7A10 mRNA

NCBI chr 1:87,829,084...87,845,073
Ensembl chr 1:87,829,175...87,845,071

G

solute carrier family 7 member 5

increases expression

Cephaloridine results in increased expression of SLC7A5 mRNA

NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823

G

solute carrier family 7 member 7

decreases expression

Cephaloridine results in decreased expression of SLC7A7 mRNA

NCBI chr15:27,822,088...27,873,121
Ensembl chr15:27,822,091...27,865,648

G

solute carrier family 8 member A1

decreases expression

Cephaloridine results in decreased expression of SLC8A1 mRNA

NCBI chr 6:13,194,609...13,547,369
Ensembl chr 6:13,194,662...13,535,628

G

secretory leukocyte peptidase inhibitor

increases expression

Cephaloridine results in increased expression of SLPI mRNA

NCBI chr 3:153,082,208...153,084,457
Ensembl chr 3:153,082,369...153,084,453

G

SET and MYND domain containing 1

increases expression

Cephaloridine results in increased expression of SMYD1 mRNA

NCBI chr 4:103,195,330...103,252,989
Ensembl chr 4:103,200,322...103,311,766

G

small nuclear RNA activating complex, polypeptide 2

increases expression

Cephaloridine results in increased expression of SNAPC2 mRNA

NCBI chr12:2,605,794...2,608,997
Ensembl chr12:2,605,810...2,608,999

G

suppressor of cytokine signaling 3

decreases expression

Cephaloridine results in decreased expression of SOCS3 mRNA

NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787

G

Spetex-2B protein

increases expression

Cephaloridine results in increased expression of SPETEX2B mRNA

G

Spetex-2D protein

increases expression

Cephaloridine results in increased expression of SPETEX2D mRNA

G

sphingosine kinase 1

increases expression

Cephaloridine results in increased expression of SPHK1 mRNA

NCBI chr10:101,758,567...101,764,240
Ensembl chr10:101,758,711...101,764,240

G

serine peptidase inhibitor, Kazal type 1

decreases expression

Cephaloridine results in decreased expression of SPINK1 mRNA

NCBI chr18:35,870,723...35,882,693
Ensembl chr18:35,824,550...35,882,642

G

SRP receptor subunit alpha

decreases expression

Cephaloridine results in decreased expression of SRPRA mRNA

NCBI chr 8:33,560,365...33,566,458
Ensembl chr 8:33,560,348...33,566,470

G

signal transducer and activator of transcription 3

increases expression

Cephaloridine results in increased expression of STAT3 mRNA

NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057

G

serine/threonine kinase 35

increases expression

Cephaloridine results in increased expression of STK35 mRNA

NCBI chr 3:117,016,819...117,049,131
Ensembl chr 3:117,016,950...117,048,066

G

signaling receptor and transporter of retinol STRA6

decreases expression

Cephaloridine results in decreased expression of STRA6 mRNA

NCBI chr 8:58,548,899...58,568,861
Ensembl chr 8:58,549,736...58,568,860

G

sulfotransferase family 1C member 2A

decreases expression

Cephaloridine results in decreased expression of SULT1C2 mRNA; Cephaloridine results in decreased expression of SULT1C2A mRNA

NCBI chr 9:6,873,697...6,904,736
Ensembl chr 9:6,874,249...6,904,734

G

sulfotransferase family 4A, member 1

increases expression

Cephaloridine results in increased expression of SULT4A1 mRNA

NCBI chr 7:115,216,066...115,240,156
Ensembl chr 7:115,216,066...115,240,085

G

surfeit 6

decreases expression

Cephaloridine results in decreased expression of SURF6 mRNA

NCBI chr 3:10,221,450...10,232,306
Ensembl chr 3:10,221,452...10,232,251

G

sushi domain containing 2

decreases expression

Cephaloridine results in decreased expression of SUSD2 mRNA

NCBI chr20:13,017,516...13,024,820
Ensembl chr20:13,017,477...13,024,903

G

spectrin repeat containing nuclear envelope protein 1

decreases expression

Cephaloridine results in decreased expression of SYNE1 mRNA

NCBI chr 1:41,512,146...41,983,382
Ensembl chr 1:41,512,030...41,983,322

G

spectrin repeat containing nuclear envelope protein 2

decreases expression

Cephaloridine results in decreased expression of SYNE2 mRNA

NCBI chr 6:94,537,088...94,848,085
Ensembl chr 6:94,537,088...94,848,064

G

synaptotagmin-like 5

increases expression

Cephaloridine results in increased expression of SYTL5 mRNA

NCBI chr X:12,775,529...13,030,134
Ensembl chr X:12,788,698...13,030,175

G

tachykinin precursor 3

increases expression

Cephaloridine results in increased expression of TAC2 mRNA

NCBI chr 7:63,562,552...63,569,170
Ensembl chr 7:63,562,552...63,569,170

G

T-box transcription factor 3

decreases expression

Cephaloridine results in decreased expression of TBX3 mRNA

NCBI chr12:36,879,924...36,894,849
Ensembl chr12:36,881,445...36,893,708

G

transcription factor 12

decreases expression

Cephaloridine results in decreased expression of TCF12 mRNA

NCBI chr 8:72,490,447...72,799,265
Ensembl chr 8:72,492,567...72,799,201

G

transcription factor 19

increases expression

Cephaloridine results in increased expression of TCF19 mRNA

NCBI chr20:3,218,756...3,222,861
Ensembl chr20:3,218,693...3,223,271

G

transferrin receptor

increases expression

Cephaloridine results in increased expression of TFRC mRNA

NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257

G

TOPBP1-interacting checkpoint and replication regulator

increases expression

Cephaloridine results in increased expression of TICRR mRNA

NCBI chr 1:133,597,618...133,639,513
Ensembl chr 1:133,597,716...133,639,523

G

timeless circadian regulator

increases expression

Cephaloridine results in increased expression of TIMELESS mRNA

NCBI chr 7:654,804...678,769
Ensembl chr 7:654,822...678,738

G

TIMP metallopeptidase inhibitor 1

increases expression

Cephaloridine results in increased expression of TIMP1 mRNA

NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664

G

toll-like receptor 2

increases expression

Cephaloridine results in increased expression of TLR2 mRNA

NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630

G

transmembrane protein 163

increases expression

Cephaloridine results in increased expression of TMEM163 mRNA

NCBI chr13:38,967,913...39,141,664
Ensembl chr13:38,968,101...39,141,452

G

transmembrane protein 252

decreases expression

Cephaloridine results in decreased expression of TMEM252 mRNA

NCBI chr 1:222,316,982...222,321,946
Ensembl chr 1:222,316,795...222,321,943

G

transmembrane protein 270

increases expression

Cephaloridine results in increased expression of TMEM270 mRNA

NCBI chr12:21,793,631...21,798,723
Ensembl chr12:21,794,130...21,798,731

G

transmembrane protein 63c

increases expression

Cephaloridine results in increased expression of TMEM63C mRNA

NCBI chr 6:106,667,389...106,738,778
Ensembl chr 6:106,672,934...106,736,990

G

transmembrane protein 86A

decreases expression

Cephaloridine results in decreased expression of TMEM86A mRNA

NCBI chr 1:97,595,910...97,600,260
Ensembl chr 1:97,595,842...97,600,260

G

TNF receptor superfamily member 12A

increases expression

Cephaloridine results in increased expression of TNFRSF12A mRNA

NCBI chr10:12,707,077...12,709,071
Ensembl chr10:12,689,890...12,709,045

G

TNF receptor superfamily member 1A

increases expression

Cephaloridine results in increased expression of TNFRSF1A mRNA

NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591

G

tensin 1

decreases expression

Cephaloridine results in decreased expression of TNS1 mRNA

NCBI chr 9:75,491,886...75,702,853
Ensembl chr 9:75,495,814...75,703,225

G

tensin 4

increases expression

Cephaloridine results in increased expression of TNS4 mRNA

NCBI chr10:84,021,965...84,041,346
Ensembl chr10:84,021,966...84,041,346

G

tonsoku-like, DNA repair protein

increases expression

Cephaloridine results in increased expression of TONSL mRNA

NCBI chr 7:108,345,704...108,360,792
Ensembl chr 7:108,346,047...108,360,750

G

DNA topoisomerase II alpha

decreases expression

Cephaloridine results in decreased expression of TOP2A mRNA

NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874

G

tryptophan hydroxylase 1

increases expression

Cephaloridine results in increased expression of TPH1 mRNA

NCBI chr 1:97,157,375...97,178,415
Ensembl chr 1:97,157,409...97,178,344

G

tribbles pseudokinase 3

increases expression

Cephaloridine results in increased expression of TRIB3 mRNA

NCBI chr 3:140,809,634...140,815,230
Ensembl chr 3:140,809,043...140,814,497

G

TLR4 interactor with leucine-rich repeats

decreases expression

Cephaloridine results in decreased expression of TRIL mRNA

NCBI chr 4:82,922,327...82,927,172
Ensembl chr 4:82,922,328...82,927,172

G

transient receptor potential cation channel, subfamily C, member 6

increases expression

Cephaloridine results in increased expression of TRPC6 mRNA

NCBI chr 8:5,759,387...5,864,000
Ensembl chr 8:5,758,935...5,828,092

G

tetratricopeptide repeat domain 39A

increases expression

Cephaloridine results in increased expression of TTC39A mRNA

NCBI chr 5:124,165,102...124,204,740
Ensembl chr 5:124,151,760...124,204,973

G

Ttk protein kinase

decreases expression

Cephaloridine results in decreased expression of TTK mRNA

NCBI chr 8:84,754,329...84,792,653
Ensembl chr 8:84,754,315...84,792,651

G

tubulin tyrosine ligase like 2

increases expression

Cephaloridine results in increased expression of TTLL2 mRNA

NCBI chr 1:52,967,183...52,976,690
Ensembl chr 1:52,968,408...52,976,697

G

tubulin, beta 3 class III

increases expression

Cephaloridine results in increased expression of TUBB3 mRNA

NCBI chr19:51,457,187...51,466,243
Ensembl chr19:51,457,184...51,466,243

G

tubulin, beta 6 class V

increases expression

Cephaloridine results in increased expression of TUBB6 mRNA

NCBI chr18:60,943,394...60,953,031
Ensembl chr18:60,943,375...60,954,418

G

thymidylate synthetase

increases expression

Cephaloridine results in increased expression of TYMS mRNA

NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536

G

ubiquitin D

increases expression

Cephaloridine results in increased expression of UBD mRNA

NCBI chr20:1,385,487...1,387,438
Ensembl chr20:1,385,864...1,408,639
Ensembl chr20:1,385,864...1,408,639

G

ubiquitin-conjugating enzyme E2C

decreases expression

Cephaloridine results in decreased expression of UBE2C mRNA

NCBI chr 3:153,506,636...153,509,036
Ensembl chr 3:153,506,636...153,513,339

G

ubiquitin-conjugating enzyme E2L 6

increases expression

Cephaloridine results in increased expression of UBE2L6 mRNA

NCBI chr 3:69,873,025...69,888,042
Ensembl chr 3:69,873,424...69,888,048

G

ubiquitin-like 7

increases expression

Cephaloridine results in increased expression of UBL7 mRNA

NCBI chr 8:58,321,279...58,340,353
Ensembl chr 8:58,320,866...58,340,344

G

ubiquitin C-terminal hydrolase L1

increases expression

Cephaloridine results in increased expression of UCHL1 mRNA

NCBI chr14:41,485,031...41,495,590
Ensembl chr14:41,485,031...41,495,590

G

UDP glucuronosyltransferase 1 family, polypeptide A2

increases expression

Cephaloridine results in increased expression of UGT1A2 mRNA

NCBI chr 9:88,791,216...88,808,465
Ensembl chr 9:88,713,184...88,808,465

G

UDP glucuronosyltransferase family 1 member A6

increases expression

Cephaloridine results in increased expression of UGT1A6 mRNA

NCBI chr 9:88,747,213...88,808,465
Ensembl chr 9:88,713,184...88,808,465

G

UDP glucuronosyltransferase family 2 member B7

increases expression

Cephaloridine results in increased expression of UGT2B7 mRNA

NCBI chr14:20,896,682...20,919,604
Ensembl chr14:20,896,682...20,919,604

G

U2AF homology motif kinase 1

increases expression

Cephaloridine results in increased expression of UHMK1 mRNA

NCBI chr13:82,396,646...82,416,292
Ensembl chr13:82,401,187...82,416,292

G

U2AF homology motif kinase 1l1

increases expression

Cephaloridine results in increased expression of UHMK1L1 mRNA

NCBI chr17:42,241,640...42,243,666

G

uridine phosphorylase 1

increases expression

Cephaloridine results in increased expression of UPP1 mRNA

NCBI chr14:83,809,495...83,829,299
Ensembl chr14:83,809,960...83,829,462

G

ubiquitin specific peptidase 24

decreases expression

Cephaloridine results in decreased expression of USP24 mRNA

NCBI chr 5:121,080,687...121,210,321
Ensembl chr 5:121,080,470...121,210,311

G

vascular cell adhesion molecule 1

increases expression

Cephaloridine results in increased expression of VCAM1 mRNA

NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958

G

V-set pre-B cell surrogate light chain 3

increases expression

Cephaloridine results in increased expression of VPREB3 mRNA

NCBI chr20:12,717,421...12,718,785
Ensembl chr20:12,716,779...12,719,520

G

WD repeat and HMG-box DNA binding protein 1

increases expression

Cephaloridine results in increased expression of WDHD1 mRNA

NCBI chr15:20,478,310...20,523,106
Ensembl chr15:20,489,291...20,523,096

G

zinc finger CCCH type containing 13

decreases expression

Cephaloridine results in decreased expression of ZC3H13 mRNA

NCBI chr15:50,607,335...50,671,802
Ensembl chr15:50,607,380...50,671,802

G

zinc finger DHHC-type palmitoyltransferase 18

decreases expression

Cephaloridine results in decreased expression of ZDHHC18 mRNA

NCBI chr 5:145,821,534...145,859,989
Ensembl chr 5:145,831,446...145,859,993

G

zinc finger AN1-type containing 2A

decreases expression

Cephaloridine results in decreased expression of ZFAND2A mRNA

NCBI chr12:15,161,601...15,172,679
Ensembl chr12:15,161,639...15,172,677

G

zinc finger protein 367

increases expression

Cephaloridine results in increased expression of ZFP367 mRNA

NCBI chr17:965,161...984,290
Ensembl chr17:965,161...984,287

cefalotin

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

ATP binding cassette subfamily B member 11

multiple interactions

[Cephalothin co-treated with Neomycin] results in increased expression of ABCB11 mRNA

NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730

G

ATP binding cassette subfamily C member 2

multiple interactions

[Cephalothin co-treated with Neomycin] results in increased expression of ABCC2 mRNA

NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238

G

ATP binding cassette subfamily C member 3

multiple interactions

[Cephalothin co-treated with Neomycin] results in increased expression of ABCC3 mRNA

NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595

G

BCL2 associated X, apoptosis regulator

increases expression

Cephalothin results in increased expression of BAX protein

NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368

G

caspase 3

multiple interactions

Cephalothin results in increased cleavage of and results in increased activity of CASP3 protein

NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648

G

cytochrome P450 family 8 subfamily B member 1

multiple interactions

[Cephalothin co-treated with Neomycin] results in decreased expression of CYP8B1 mRNA

NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166

G

fibroblast growth factor 19

multiple interactions

[Cephalothin co-treated with Neomycin] results in increased expression of FGF15 mRNA

NCBI chr 1:200,056,526...200,060,980
Ensembl chr 1:200,056,644...200,060,287

G

NPC1 like intracellular cholesterol transporter 1

multiple interactions

[Cephalothin co-treated with Neomycin] results in increased expression of NPC1L1 mRNA

NCBI chr14:81,071,448...81,091,113
Ensembl chr14:81,071,451...81,091,113

G

nuclear receptor subfamily 5, group A, member 2

multiple interactions

[Cephalothin co-treated with Neomycin] results in increased expression of NR5A2 mRNA

NCBI chr13:48,313,634...48,433,494
Ensembl chr13:48,316,301...48,433,326

G

solute carrier family 10 member 1

multiple interactions

[Cephalothin co-treated with Neomycin] results in increased expression of SLC10A1 mRNA

NCBI chr 6:100,613,045...100,626,670
Ensembl chr 6:100,613,045...100,626,670

G

solute carrier family 25 member 20

multiple interactions

Cephalothin binds to and results in decreased activity of SLC25A20 protein; Cephalothin inhibits the reaction [SLC25A20 protein results in increased transport of Carnitine]

NCBI chr 8:109,365,056...109,386,512
Ensembl chr 8:109,365,002...109,386,512

G

SLC51 subunit beta

multiple interactions

[Cephalothin co-treated with Neomycin] results in decreased expression of SLC51B mRNA

NCBI chr 8:65,931,891...65,939,953
Ensembl chr 8:65,931,890...65,940,145

G

solute carrier organic anion transporter family member 1B2

multiple interactions

[Cephalothin co-treated with Neomycin] results in increased expression of SLCO1B2 mRNA

NCBI chr 4:174,551,463...174,619,988
Ensembl chr 4:174,551,480...174,619,981

G

tumor protein p53

increases expression

Cephalothin results in increased expression of TP53 protein

NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524

G

vitamin D receptor

multiple interactions

[Cephalothin co-treated with Neomycin] results in increased expression of VDR mRNA

NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677

cefazolin

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

dihydrofolate reductase

decreases activity

Cefazolin results in decreased activity of DHFR protein

NCBI chr 2:23,585,876...23,611,199
Ensembl chr 2:23,586,031...23,613,713

G

glutathione-disulfide reductase

multiple interactions
increases expression

Cefazolin results in increased expression of and results in decreased activity of GSR protein
Cefazolin results in increased expression of GSR mRNA

NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661

G

RT1 class II, locus DOa

affects expression

Cefazolin affects the expression of HLA-DOA mRNA

NCBI chr20:4,753,587...4,756,590
Ensembl chr20:4,753,598...4,756,577

G

RT1 class Ib, locus M3, gene 1

affects expression

Cefazolin affects the expression of HLA-G mRNA

NCBI chr20:1,323,976...1,328,126
Ensembl chr20:1,287,521...1,328,117

G

solute carrier family 22 member 8

increases uptake

SLC22A8 protein results in increased uptake of Cefazolin

NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450

G

solute carrier family 25 member 20

multiple interactions

Cefazolin binds to and results in decreased activity of SLC25A20 protein; Cefazolin inhibits the reaction [SLC25A20 protein results in increased transport of Carnitine]

NCBI chr 8:109,365,056...109,386,512
Ensembl chr 8:109,365,002...109,386,512

cefdinir

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

solute carrier family 22 member 6

multiple interactions
increases uptake

cefdinir inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid]
SLC22A6 protein results in increased uptake of cefdinir

NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173

G

solute carrier family 22 member 8

multiple interactions
increases uptake

cefdinir inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]
SLC22A8 protein results in increased uptake of cefdinir

NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450

cefepime

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

Rho GTPase activating protein 45

affects expression

cefepime affects the expression of ARHGAP45 mRNA

NCBI chr 7:9,674,873...9,690,286
Ensembl chr 7:9,674,897...9,690,268

G

catalase

multiple interactions

cefepime inhibits the reaction [Amikacin results in decreased activity of CAT protein]

NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478

G

dihydrofolate reductase

decreases activity

cefepime results in decreased activity of DHFR protein

NCBI chr 2:23,585,876...23,611,199
Ensembl chr 2:23,586,031...23,613,713

G

phosphogluconate dehydrogenase

decreases activity

cefepime results in decreased activity of PGD protein

NCBI chr 5:159,582,746...159,598,945
Ensembl chr 5:159,561,271...159,742,778

G

RT1 class II, locus Db1

affects expression

cefepime affects the expression of HLA-DRB1 mRNA

NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258

cefixime

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

RAB8A, member RAS oncogene family

multiple interactions
increases uptake

[RAB8A protein results in increased localization of SLC15A1 protein] which results in increased uptake of Cefixime
RAB8A protein results in increased uptake of Cefixime

NCBI chr16:17,654,027...17,675,385
Ensembl chr16:17,654,034...17,675,678

G

solute carrier family 15 member 1

multiple interactions
increases uptake

[RAB8A protein results in increased localization of SLC15A1 protein] which results in increased uptake of Cefixime
SLC15A1 protein results in increased uptake of Cefixime

NCBI chr15:98,537,641...98,582,544
Ensembl chr15:98,537,641...98,582,545

cefmetazole

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

ATP binding cassette subfamily C member 4

increases transport

ABCC4 protein results in increased transport of Cefmetazole

NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283

cefonicid

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

solute carrier family 25 member 20

multiple interactions

Cefonicid binds to and results in decreased activity of SLC25A20 protein; Cefonicid inhibits the reaction [SLC25A20 protein results in increased transport of Carnitine]

NCBI chr 8:109,365,056...109,386,512
Ensembl chr 8:109,365,002...109,386,512

cefoperazone

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

solute carrier family 22 member 7

multiple interactions

Cefoperazone inhibits the reaction [SLC22A7 protein results in increased uptake of Glutarates]

NCBI chr 9:14,547,073...14,554,354
Ensembl chr 9:14,547,849...14,553,921

cefoselis sulfate

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

solute carrier family 22 member 6

multiple interactions

cefoselis inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid]

NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173

G

solute carrier family 22 member 8

increases uptake
multiple interactions

SLC22A8 protein results in increased uptake of cefoselis
cefoselis inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]

NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450

cefotaxime

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

BCL2 associated X, apoptosis regulator

increases expression

Cefotaxime results in increased expression of BAX protein

NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368

G

interleukin 10

multiple interactions

Cefotaxime inhibits the reaction [Lipopolysaccharides results in increased secretion of IL10 protein]

NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313

G

phosphogluconate dehydrogenase

decreases activity

Cefotaxime results in decreased activity of PGD protein

NCBI chr 5:159,582,746...159,598,945
Ensembl chr 5:159,561,271...159,742,778

G

RT1 class I, locus CE5

affects expression

Cefotaxime affects the expression of HLA-F mRNA

NCBI chr20:3,403,418...3,479,476

G

tumor protein p53

increases expression

Cefotaxime results in increased expression of TP53 protein

NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524

cefotetan

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

potassium voltage-gated channel subfamily H member 2

decreases activity

Cefotetan results in decreased activity of KCNH2 protein

NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008

cefotiam

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

solute carrier family 22 member 6

multiple interactions

Cefotiam inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid]

NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173

G

solute carrier family 22 member 8

increases uptake
multiple interactions

SLC22A8 protein results in increased uptake of Cefotiam
Cefotiam inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]

NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450

cefoxitin

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

interferon gamma

multiple interactions

[Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of IFNG mRNA]

NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375

G

inhibitor of nuclear factor kappa B kinase subunit beta

multiple interactions

[Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of IKBKB mRNA]

NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250

G

interleukin 10

multiple interactions

[Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of IL10 mRNA]

NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313

G

interleukin 1 beta

multiple interactions

[Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of IL1B mRNA]

NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415

G

interleukin 6

multiple interactions

[Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of IL6 mRNA]

NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178

G

MYD88, innate immune signal transduction adaptor

multiple interactions

[Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of MYD88 mRNA]

NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415

G

RELA proto-oncogene, NF-kB subunit

multiple interactions

[Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of RELA mRNA]

NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484

G

RT1 class I, locus CE16

affects expression

Cefoxitin affects the expression of HLA-A mRNA

NCBI chr20:3,257,109...3,260,747
Ensembl chr20:3,257,123...3,279,563

G

RT1 class II, locus Ha

affects expression

Cefoxitin affects the expression of HLA-DPA1 mRNA

NCBI chr20:4,760,631...4,770,662
Ensembl chr20:4,760,118...4,770,244

G

transforming growth factor, beta 1

multiple interactions

[Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of TGFB1 mRNA]

NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847

G

toll-like receptor 2

multiple interactions

[Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of TLR2 mRNA]

NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630

G

tumor necrosis factor

multiple interactions

[Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of TNF mRNA]

NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629

G

TNF receptor associated factor 6

multiple interactions

[Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of TRAF6 mRNA]

NCBI chr 3:87,963,517...87,988,316
Ensembl chr 3:87,963,514...87,983,507

cefpodoxime

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

prolactin

increases expression

Cefpodoxime results in increased expression of PRL protein

NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062

ceftaroline

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

defensin beta 5

multiple interactions

Ceftaroline inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Tobacco Smoke Pollution] results in decreased secretion of DEFB4A protein]; Ceftaroline inhibits the reaction [IL1B protein results in increased expression of DEFB4A mRNA]; Ceftaroline inhibits the reaction [Tobacco Smoke Pollution inhibits the reaction [IL1B protein results in increased expression of DEFB4A mRNA]]; Ceftaroline inhibits the reaction [Tobacco Smoke Pollution results in decreased expression of and results in decreased secretion of DEFB4A protein]; Ceftaroline inhibits the reaction [Tobacco Smoke Pollution results in decreased secretion of DEFB4A protein]

PMID:27397760 PMID:28720485

NCBI chr16:70,612,985...70,615,389
Ensembl chr16:70,613,146...70,615,467

G

interleukin 1 beta

multiple interactions

Ceftaroline inhibits the reaction [IL1B protein results in increased expression of DEFB4A mRNA]; Ceftaroline inhibits the reaction [Tobacco Smoke Pollution inhibits the reaction [IL1B protein results in increased expression of DEFB4A mRNA]]

NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415

G

toll-like receptor 2

multiple interactions

Ceftaroline inhibits the reaction [Tobacco Smoke Pollution results in increased expression of TLR2 protein]

NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630

G

toll-like receptor 4

multiple interactions

Ceftaroline inhibits the reaction [Tobacco Smoke Pollution results in increased expression of TLR4 protein]

NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628

G

tumor necrosis factor

multiple interactions

Ceftaroline inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Tobacco Smoke Pollution] results in increased secretion of TNF protein]; Ceftaroline inhibits the reaction [Tobacco Smoke Pollution results in increased secretion of TNF protein]

NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629

ceftazidime pentahydrate

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

ATP binding cassette subfamily C member 4

increases transport

ABCC4 protein results in increased transport of Ceftazidime

NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283

G

dihydrofolate reductase

decreases activity

Ceftazidime results in decreased activity of DHFR protein

NCBI chr 2:23,585,876...23,611,199
Ensembl chr 2:23,586,031...23,613,713

G

heat shock transcription factor 1

decreases activity

Ceftazidime results in decreased activity of HSF1 protein

NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:108,196,056...108,223,011

G

interleukin 10

multiple interactions

Ceftazidime inhibits the reaction [Lipopolysaccharides results in increased secretion of IL10 protein]

NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313

ceftibuten

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

solute carrier family 15 member 1

multiple interactions

[Zinc results in decreased activity of SLC15A1 protein] which results in decreased uptake of ceftibuten

NCBI chr15:98,537,641...98,582,544
Ensembl chr15:98,537,641...98,582,545

G

solute carrier family 22 member 6

increases uptake
multiple interactions

SLC22A6 protein results in increased uptake of ceftibuten
ceftibuten inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid]

NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173

G

solute carrier family 22 member 8

increases uptake
multiple interactions

SLC22A8 protein results in increased uptake of ceftibuten
ceftibuten inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]

NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450

ceftizoxime

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

dihydrofolate reductase

decreases activity

Ceftizoxime results in decreased activity of DHFR protein

NCBI chr 2:23,585,876...23,611,199
Ensembl chr 2:23,586,031...23,613,713

G

solute carrier family 22 member 6

multiple interactions
increases uptake

Ceftizoxime inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid]
SLC22A6 protein results in increased uptake of Ceftizoxime

NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173

G

solute carrier family 22 member 8

increases uptake
multiple interactions

SLC22A8 protein results in increased uptake of Ceftizoxime
Ceftizoxime inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate]

NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450

ceftriaxone

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

angiotensin converting enzyme 2

decreases expression

Ceftriaxone results in decreased expression of ACE2 mRNA

NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977

G

actin, beta

increases expression

Ceftriaxone results in increased expression of ACTB mRNA

NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877

G

beta-secretase 1

decreases expression

Ceftriaxone results in decreased expression of BACE1 mRNA

NCBI chr 8:46,142,060...46,166,268
Ensembl chr 8:46,142,116...46,165,876

G

catalase

decreases expression
multiple interactions

Ceftriaxone results in decreased expression of CAT protein
Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased activity of CAT protein]; ropinirole promotes the reaction [Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased activity of CAT protein]]

PMID:19442074 PMID:25053526

NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478

G

dihydrofolate reductase

decreases activity

Ceftriaxone results in decreased activity of DHFR protein

NCBI chr 2:23,585,876...23,611,199
Ensembl chr 2:23,586,031...23,613,713

G

endothelin converting enzyme 1

increases expression

Ceftriaxone results in increased expression of ECE1 mRNA

NCBI chr 5:150,077,679...150,179,375
Ensembl chr 5:150,077,644...150,179,371

G

erythropoietin

increases expression

Ceftriaxone results in increased expression of EPO mRNA

NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946

G

glutamate ionotropic receptor AMPA type subunit 1

multiple interactions

Ceftriaxone inhibits the reaction [Cocaine increases expression of Gria1 protein in the nucleus accumbens]

RGD

NCBI chr10:41,210,713...41,527,283
Ensembl chr10:41,210,713...41,527,283

G

insulin degrading enzyme

increases expression

Ceftriaxone results in increased expression of IDE mRNA

NCBI chr 1:235,002,984...235,102,448
Ensembl chr 1:234,995,351...235,102,440

G

interleukin 1 beta

multiple interactions

Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of IL1B protein]; ropinirole promotes the reaction [Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of IL1B protein]]

NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415

G

membrane metallo-endopeptidase

increases expression

Ceftriaxone results in increased expression of MME mRNA

NCBI chr 2:147,686,913...147,803,808
Ensembl chr 2:147,722,086...147,803,792

G

solute carrier family 1 member 2

multiple interactions
increases expression

Ceftriaxone inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of SLC1A2 protein]; Ceftriaxone inhibits the reaction [Cocaine results in decreased expression of SLC1A2 protein]; Ceftriaxone inhibits the reaction [JZL195 results in decreased expression of and affects the folding of SLC1A2 protein]; Ceftriaxone promotes the reaction [Kainic Acid results in increased expression of SLC1A2 protein]
Ceftriaxone results in increased expression of SLC1A2 protein

PMID:19625514 PMID:19717140 PMID:28257918 PMID:29045497 PMID:29432698

NCBI chr 3:89,005,129...89,135,469
Ensembl chr 3:89,005,129...89,126,498

G

solute carrier family 7 member 11

multiple interactions

Ceftriaxone inhibits the reaction [Cocaine results in decreased expression of SLC7A11 protein]

NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536

G

tumor necrosis factor

multiple interactions

Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of TNF protein]; ropinirole promotes the reaction [Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of TNF protein]]

NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629

cefuroxime

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

catalase

decreases activity

Cefuroxime results in decreased activity of CAT protein

NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478

G

interleukin 10

multiple interactions

Cefuroxime inhibits the reaction [Lipopolysaccharides results in increased secretion of IL10 protein]

NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313

G

NFE2 like bZIP transcription factor 2

decreases activity

Cefuroxime results in decreased activity of NFE2L2 protein

NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737

G

nuclear receptor subfamily 1, group I, member 3

decreases activity

Cefuroxime results in decreased activity of NR1I3 protein

NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906

G

peroxisome proliferator activated receptor alpha

decreases activity

Cefuroxime results in decreased activity of PPARA protein

NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346

G

RT1 class Ia, locus A2

affects expression

Cefuroxime affects the expression of HLA-E mRNA

NCBI chr20:4,870,939...4,910,183

G

RT1 class II, locus Bb

affects expression

Cefuroxime affects the expression of HLA-DQB1 mRNA

NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597

cephalexin

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

RT1 class II, locus Ha

affects expression

Cephalexin affects the expression of HLA-DPA1 mRNA

NCBI chr20:4,760,631...4,770,662
Ensembl chr20:4,760,118...4,770,244

G

solute carrier family 15 member 1

increases transport

SLC15A1 protein results in increased transport of Cephalexin

NCBI chr15:98,537,641...98,582,544
Ensembl chr15:98,537,641...98,582,545

cephalosporin C

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

ATP binding cassette subfamily C member 4

increases transport

ABCC4 protein results in increased transport of cephalosporin C

NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283

cephradine

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

solute carrier family 15 member 1

multiple interactions

[Zinc results in decreased activity of SLC15A1 protein] which results in decreased uptake of Cephradine

NCBI chr15:98,537,641...98,582,544
Ensembl chr15:98,537,641...98,582,545

Term paths to the root

Path 1
Term	Annotations
CHEBI ontology	19874
role	19844
biological role	19842
antimicrobial agent	18240
heterocyclic antibiotic	3017
organonitrogen heterocyclic antibiotic	2983
beta-lactam antibiotic	813
cephem	549
[(2,2-dimethylpropanoyl)oxy]methyl (6R,7R)-7-\{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)pent-2-enoyl]amino\}-3-[(carbamoyloxy)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate	0
cephalosporin +	548
cephamycin +	14
Path 2
Term	Annotations
CHEBI ontology	19874
subatomic particle	19872
composite particle	19872
hadron	19872
baryon	19872
nucleon	19872
atomic nucleus	19872
atom	19872
main group element atom	19811
p-block element atom	19811
carbon group element atom	19751
carbon atom	19748
organic molecular entity	19748
heteroorganic entity	19505
organochalcogen compound	19268
organooxygen compound	19184
carbon oxoacid	18654
carboxylic acid	18651
carboacyl group	17694
univalent carboacyl group	17694
carbamoyl group	17545
carboxamide	17545
lactam	8389
beta-lactam	828
beta-lactam antibiotic	813
cephem	549
[(2,2-dimethylpropanoyl)oxy]methyl (6R,7R)-7-\{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)pent-2-enoyl]amino\}-3-[(carbamoyloxy)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate	0
cephalosporin +	548
cephamycin +	14

paths to the root